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palavras-chave 
 
Proteína Precursora de Amilóde de Alzheimer (PPA), fosforilação, 
diferenciação neuronal, neurite, Ácido Retinóico, células SH-SY5Y, Domínio 
Intracelular da PPA (DIP) 
resumo 
 
 
A Proteína Precursora de Amilóide de Alzheimer (PPA) é uma proteína 
membranar tipo 1 sujeita a processamento proteolítico que tem sido associada 
a funções como adesão celular, sobrevivência, migração e diferenciação. 
Apesar de lhe terem sido atribuídas funções na neuritogénese, os dados 
experimentais obtidos até à data que envolveram modulação dos níveis da 
PPA revelam-se contraditórios. De facto, enquanto a adição do fragmento PPA 
secretado (PPAs) ao meio celular favorece a neuritogénese, a quantidade de 
PPA celular e de outros fragmentos da PPA poderão já não constituir um 
benefício para este processo. Adicionalmente, dados preliminares do 
laboratório de Neurociências do Centro de Biologia Celular sugerem que a 
PPAp (PPA fosforilada na S655) poderá ser fundamental na diferenciação 
neuronal mediada pela PPA, nomeadamente por aumentar a proteólise da 
PPA a PPAs ou a ligação da PPA a sinais de transdução específicos. 
No presente trabalho, avaliou-se a capacidade da PPA e PPAp em mediar o 
período inicial de diferenciação neuronal induzida por ácido retinóico. Para tal 
recorreu-se a células de neuroblastoma SH-SY5Y, um modelo celular do tipo 
neuronal bem estabelecido para estudos de diferenciação. Adicionalmente, 
várias ferramentas moleculares, como PPA-GFP selvagem e fosfomutantes 
foram usadas. A avaliação da diferenciação incluiu a análise de vários 
parâmetros neuritogénicos por microscopia de luz (de campo claro e de 
fluorescência), nomeadamente monitorização de células diferenciadas e 
análises morfométricas das células transfectadas e da população geral. Os 
níveis de PPA e PPAs, e de proteínas relacionadas com citosqueleto e suas 
modificações pós-traducionais (MAP2, Tubulina Acetilada e Actina) também 
foram quantificados. Além do mais, a influência do DIP na diferenciação 
neuronal dependente de PPA foi avaliada usando um composto farmacológico 
para inibir a sua produção.  
De um modo geral, os resultados obtidos demonstram que a PPA, PPAs e DIP 
modulam a neuritogénese de um modo complexo e ordenado. Enquanto a 
indução de níveis altos de expressão de PPA (48h) podem ser detrimentais 
para a diferenciação tipo-neuronal, de uma forma dependente de DIP, 
induções mais breves (24h) beneficiam este processo de um modo 
dependente da fosforilação na S655, potencialmente envolvendo a secreção 
de PPA e rearranjos específicos do citosqueleto. 
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abstract 
 
Amyloid Precursor Protein (APP) is a type 1 membrane protein that suffers 
proteolytic cleavages and has been implicated in roles such as cell adherence, 
survival, migration and differentiation. Although a role in neuritogenesis has 
been attributed to APP, some contradictory results have been reported 
regarding the benefits of knocking-down or overexpressing APP. Further, while 
the addition of the APP proteolytic sAPP (secreted APP) fragment to the cell 
medium enhances neuritogenesis, the amount of cellular APP and other APP 
fragments may be deleterious for this process. Further, preliminary work from 
the Neuroscience laboratory of the Center for Cell Biology indicated that pAPP 
(APP phosphorylated at the S655 residue) can potentially be crucial in APP-
mediated neuronal differentiation, for example by increasing APP cleavage to 
its biological fragment sAPP or APP binding to specific signal transducers.  
In this work, the capacity of APP and pAPP to mediate neuronal differentiation 
was tested, in the initial period of retinoic acid (RA)-induced SH-SY5Y cells 
differentiation. These neuroblastoma cells are a well documented neuronal-like 
cell model used in neuronal differentiation studies. Several molecular tools 
were used, including wild-type and phosphomutants APP-GFP. The evaluation 
of differentiation included neuritogenic output analysis by bright field and 
epifluorescence microscopy, using various approaches. Namely scoring the 
number of differentiated cells and performing morphometric analyses of 
transfected cells and of the all cellular population. The levels of APP and 
medium secreted sAPP, and of cytoskeleton-related proteins and post-
translational modifications, such as MAP2, Acetylated Tubulin and Actin were 
also quantified by Western blot analysis, and related to the morphological 
parameters. Additionally, the potential role of AICD in APP-mediated neuronal 
differentiation was inferred from pharmacologic assays, where its generation is 
inhibited.  
Together the results obtained show that APP, sAPP and AICD modulate 
neuritogenesis in a complex and well-ordered manner. While long-term  
increases in APP can be detrimental to neuronal-like differentiation, in an 
AICD-dependent manner, short-term increases benefit this process in an APP 
S655 phosphorylation dependent manner, potentially involving sAPP secretion 
and specific cytoskeleton rearrangements.  
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1. Introduction 
1.1. The Neuron 
The Human brain consists of over 1011 neurons, specialized cells that exhibit great 
variability in their size (cell bodies range from 5 to 100 μm diameter) and shapes[1].  
The basic cellular organization of neurons resembles that of other cells; however, they are 
clearly distinguished by their specialization for intercellular communication. They usually have a 
rounded or polygonal cell body (perikaryon or soma) from which long, branched extensions (the 
neurites), normally arise (See Figure 1). This extensive branching is the most distinct feature of 
these cells specialization in communication[2], and include two morphological and molecular 
distinct type of processes, axons and dendrites. 
 
 
Figure 1. Schematic representation of the typical branching structure of a neuron. In this figure we can visualize the 
multiple dendrites and a longer axon arising from the cell body. The axon terminals, specialized endings of the axon, are 
also represented. Adapted from http://www.3dscience.com/3D_Models/Biology/Cells/Neuron.php (December, 2010) 
 
Axons are typically long, thin, and relatively uniform in diameter, and they branch at right 
angles. On the other hand, dendrites are relatively short and thick as they emerge from the cell 
body, but their calibre decreases with distance from the cell body, and they branch in a Y-shaped 
pattern[3]. Besides their length, the two types of processes differ from each other in morphology, 
in capacity for protein synthesis, in some molecular constituents of their cytoskeletons and 
plasma membranes, and in synaptic polarity [4]. Table 1 summarizes the main differences existing 
between the different regions of a neuron. The axon originates from a specialized region, the 
axon hillock, located either in the soma or in the proximal segment of a dendrite. These structures 
usually conduct information away from the cell body, possessing specialized endings – axon 
terminals – which come in close connection with the membrane of the target cell. In other hand, 
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dendrites primary function is to receive and integrate information from other neurons and the 
complexity of each dendritic arbour varies accordingly to neuron type and the number of inputs 
that a particular neuron receives. Thus, dendrites represent the afferent system of the neuron, 
and synapses occur either on small projections called dendritic spines or on the smooth dendritic 
surface[5]. 
Table 1. Neurons structure and ultra-structure. Neurons have 3 specialized regions that have different organelle 
composition and molecular cytoskeleton constituents: the cell body or soma, the axon, and the dendrites[5-6].  
 Main organelles Neuronal Cytoskeleton 
Nucleus 
Reticulum and 
ribosomes 
Golgi 
complex 
Mitochondria 
Neurofilaments 
(NFs) 
Microtubules 
(MTs) 
Microfilaments 
(MFs) 
S
o
m
a
 
Large, round 
and 
euchromatic; 
One or more 
prominent 
nucleoli. 
Rich in smooth 
endoplasmic 
reticulum and 
free 
polyribosomes 
– presence of 
Nissl bodies. 
Close to 
the 
nucleus.  
Presence of 
large 
numbers;  
NFs,
 
namely NF60 
and NF65, are 
less abundant 
than in the
 
axon; 
but contain 
proportionally
 
more NF60 than 
the axons. 
Random 
dispersed.  
Short oligomers 
of actin organized 
into a meshwork 
most apparent 
near the plasma 
membrane and in 
the vicinity of 
axonal MTs 
A
xo
n
 
 Absent. 
The axon 
hillock is free of 
Nissl bodies. 
Opposite 
(and 
only) the 
axon 
hillock. 
Greater 
density in the 
axon hillock, 
at nodes, and 
in 
presynaptic 
endings. 
Mature axons: 
heavily 
phosphorylated; 
Growing axons: 
express 
calmodulin-
binding 
membrane-
associated 
phosphoprotein, 
growth-
associated 
protein-43 (GAP-
43), and poorly 
phosphorylated 
NFs. 
Have intrinsic 
polarity with 
rapidly growing 
ends away 
from the soma; 
Tau is the most 
abundant 
microtubule-
associated 
protein. 
 
Special 
concentrated at 
the axon hillock 
and in 
presynaptic 
terminals 
D
e
n
d
ri
te
s 
 Contain 
smooth 
endoplasmic 
reticulum (and 
ribosomes) 
Near  the 
bases of 
the main 
dendrites 
Present; 
however 
rarely in 
filopodia and 
simple 
spines. 
Contain few or 
no NFs. 
NFs proteins 
poorly 
phosphorylated 
MTs exhibit 
mixed 
polarities. 
Express the 
microtubule-
associated 
protein (MAP-
2) 
Particularly 
concentrated in 
dendritic spines 
and growth 
cones; growth 
cones contain 
many longer MFs, 
with bundles of 
MFs in the 
filopodia and 
lamellipodia. 
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1.2. Neuronal growth, polarization and differentiation 
Structurally, the neuron is a complex cell containing 3 distinct regions with specific 
functions: the cell body, the main site of synthesis of neuronal proteins and membranes; an axon, 
specialized for the conduction of action potential, and multiple dendrites, which are specialized to 
receive chemical signals from the axon termini of other neurons. A single axon in the central 
nervous system can synapse with many neurons and induce responses in all of them 
simultaneously; on the other hand, neurons have extremely long dendrites with complexes 
branches that allow them to form synapses with and receive signals from a large number of other 
neurons, possibly up to a thousand. Give such complexity, the central challenge of neuronal 
development is to explain how the cell polarize into three different highly organized regions, 
namely how the axons and dendrites grow out, find the right target cells, and synapse with them 
selectively in order to create a functional network. 
The nervous system in the vertebrates develops chiefly from two sets of cells of the 
ectoderm: the neural tube (the origin of the central nervous system) and the neural crest (gives 
rise to the peripheral nervous system). The early neural epithelium consists of a homogeneous 
population of pluripotent cells in different phases of the proliferative cycle which is reflected in 
miscellaneous appearances[5]. At some point in development, stem cells—the dividing cells that 
populate the proliferative zones of the developing brain—undergo asymmetrical divisions that 
produce both another stem cell and a neuronal precursor (called a neuroblast) that will never 
again undergo cell division, instead it will suffer a series of events leading to neuronal polarization 
and the development of a mature neuron. Therefore, for each neuron it can be assigned a 
“birthday” and neurons of a given type generally have the same birthdays which occur within a 
strictly limited period of development[2]. The state of the art in neuronal development and 
differentiation, points to a clear existence of an intrinsic program that is activated during the early 
stages of neuronal differentiation and controls the polarization of neurons. However, this intrinsic 
“polarity program” is subject to modification by environmental signals and cell injury[7].  
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1.2.1. Developmental stages of neurons 
Neuronal polarization can be divided into several specific steps, either in vivo or in vitro 
dissociated neuronal cultures.  
In vivo, before differentiate, the immature neuron or its precursor commonly migrates 
from its birthplace and settles in some other location. As a rule, the axon and the dendrites begin 
to grow out from the nerve cell body during migration. While migrating, postmitotic neurons 
endure extensive stereotypical changes and acquire their polarity from the emergence of a 
leading process and a trailing process, each becoming the axon or the dendrite. This is true for 
neuronal subpopulations undergoing long-range migration as cerebellar granule neurons, cortical 
(Figure 2) and hippocampal pyramidal neurons. However, in the case of retinal ganglion cells and 
bipolar retinal cells, for example, the postmitotic neurons can inherit their axon and dendrite 
polarity directly from the apico-basal polarity of their progenitors[8-9]. 
 
 
Figure 2. Polarization of cortical neurons in vivo. Neurons are generated between E11 and E17 by radial glial 
progenitors in the ventricular zone (VZ) of the neocortex. Upon cell cycle exit through asymmetric cell division, the 
postmitotic neuron (blue) begins to rapidly extend multiple neurites. Then, one major process forms in the radial 
direction and becomes the leading process (LP). At this point, the neuron initiates radial translocation along a radial glial 
process and leaves behind a trailing process (TP), which elongates tangentially in the intermediate zone (IZ) (red). The 
cell body continues to translocate toward the top of the cortical plate (CP), its final destination, while the axon rapidly 
elongates. The leading process gives rise to the apical dendrite (green), which initiates local branching in the marginal 
zone (MZ). During the first postnatal weeks of development, pyramidal neurons acquire other key features of their 
terminal polarity such as the axon initiation segment (AIS; yellow cartridge) and dendritic spines (gray protusions). 
Adapted from reference [8]. 
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Dissociated rodent hippocampal neurons are a typical and well establish model system for 
studying neuronal polarization. Embryonic hippocampal neurons in culture acquire their 
characteristic polarized morphology during five distinct stages (illustrated in Figure 3), as first 
described by Dotti et al (1988). The events range from stage 1, cells bearing immature neurites, to 
stage 5, functional differentiated neurons harbouring dendritic spines and synapses. In their 
report, the authors note that, whereas the events of stages 1-4 appear to be part of an 
endogenously determined program of neuronal development, cell interactions play an important 
role in modulating the maturation of hippocampal neurons since the distinction between stages 4 
and 5 represent a change in the control of the development. 
 
Figure 3. Stages of development of hippocampal neurons in culture. The red circle indicates growth cones. IV: in vitro; 
DIV: days in vitro. Adapted from reference[3]. 
 
The main event in stage 1 hippocampal neurons is the formation of lamellipodia which 
develop around the periphery of the cell soon after the cells attach to the substrate. Changes in 
these structures were correlated to the formation of neurites, as lamellipodia break up into 
discrete motile patches that will become the neuritic growth cones. In stage 2 the lamellipodia are 
transformed into minor processes that extend to a length of 15-25 μm – the neurites. Once they 
reach this length, they stop net elongation, although continue to extend and retract for short 
distances. The stage 3 is marked by the formation and growth of the axon. One of the minor 
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processes begins to grow at a much more rapid rate (about 5-10 times greater than the other 
processes) and becomes the future axon, while the other neurites remain quiescent. As a result, 
stage 3 neurons have a single axon and several short neurites, which implies that the cell has 
become polarized. Although stage 3 neurons present an actively growing neurite that will become 
the axon, axon formation is still very flexible at this stage. Indeed, cutting the axon to the length 
of the minor neurites makes the process of axon specification random as initially. However, if the 
cut axon is still 10 μm longer than the other processes, the same cut one will re-grow as axon[10]. 
Stage 4 comprehends the growth of dendrites that similar to axon develop from the minor 
processes that appear during the first day in culture. Besides starting later than the axon growth, 
dendrites grow more slowly than axons. Additionally, unlike axons, several dendrites grow at the 
same time. Eventually, after seven days in culture, neurons form synaptic contacts and 
spontaneous electrical activity propagates throughout the neuronal network[4, 11].  
Summarizing, and accordingly to Bradke and Dotti (2000), neuronal polarization occurs in 
three different, succeeding steps: initially polarization seems to be solely morphological, then a 
molecular polarization occurs with segregation of axonal and dendritic proteins, upon the 
segregation of the cytoskeleton proteins and the maturation of the sorting and transport 
machinery for membrane proteins. Finally, the cell reaches a state of functional polarization when 
the molecular segregation creates different domains in a cell, accordingly to the different 
functions a neuron fulfills[10].  
It is worth pointing out that  axon-dendrite polarization was first postulated to be an 
outgrowth of the soma by His (1886) and Cajal (1890), a theory posteriorly validated by the 
experiments of Ross Harrison in 1907[2]. Nowadays, the events leading to the emergence of the 
dendrite and the axon are collectively called as “symmetry-breaking” events[8], as neurons start 
out as simple symmetric spheres, gradually adopting its complex polarize morphology.   
 
1.2.2. Alterations in cytoskeleton dynamics and membrane trafficking  
Differentiated neurons contain several compartments with distinct membrane and 
cytoskeleton proteins. This highly organized structure is imperative for unidirectional signal 
propagation in neurons[12]. The cytoskeleton both establishes and maintains polarity in neurons. 
The rearrangements of actin and microtubules cytoskeletons are crucial for the initial 
establishment of polarity. Of central importance for axon formation and neuronal polarity is the 
growth cone which is a highly motile cellular compartment at the tips of growing axons that has 
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the ability to sense extracellular cues and transducing those signals to the cytoskeleton. The 
growth cone is a broad flat expansion, with many long microspikes or filopodia that are 
protrusions of F-actin, and some veil-like sheets of branched actin, the lamellipodia (see Figure 4).  
The filopodia attach to the substrate and exert a force that pulls the rest of the cell forward, 
allowing it to move by elongation[1-2].  
 
Figure 4. Schematic representation of the 
growth cone structure. The microtubules are 
distributed along the axonal shaft and protrude 
into the central region of the growth cone. 
Actin is found mainly within the peripheral 
region of the growth cone enclosing filopodia 
and lamellipodia. Reproduced from the 
reference[13]. 
 
 
First (stage 2 neurons), the future axon shows enhanced growth cone dynamics and, 
thereby, actin turnover, whereas the future dendrites, quiescent at that moment, have a static 
growth cone with a rigid actin cytoskeleton[13].  Such local actin instability may cause reduced 
obstruction of microtubule protrusion and, consequently, of neurite outgrowth. Figure 5 
illustrates these cytoskeleton rearrangements in neuronal polarization.  
 
Figure 5. Cytoskeleton rearrangements in neuronal polarization. A. Unpolarized neurons with several equal neurites. 
B. In the future axon starts to occur changes in the cytoskeleton dynamics, namely, actin instability and increased 
microtubule stability. Stable microtubules are recognized by particular kinesin motors that induced unidirectional 
membrane trafficking toward the axon. C. This neurite starts elongating rapidly and a morphologically polarized neuron 
bearing an axon is formed. Reproduced from the reference[12]. 
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Actin dynamics are regulated by actin nucleating, severing, branching, and bundling 
proteins[13]. The basis of the actin cytoskeleton is the polymerization of ATP-bound globular actin 
(G-actin) in helical actin filaments (F-actin). Cofilin has the ability to increase actin dynamics by 
filament severing and depolymerization. The released G-actin is sequestered, for example, by 
profilin, since elongation of existing or newly nucleated filaments demands local release of G-actin 
from profilin. Nucleation-promoting factors, such as WASP, have the ability to release G-actin. 
Capping proteins such as CapZ prevent filament elongation. In the other hand, anti-capping 
proteins as Ena/VASP family prevent the binding of capping proteins, allowing filament 
elongation. Furthermore, branching of the actin filaments can be initiated by the Arp2/3 complex 
and bundling is mediate by fascin[12]. 
Axonal microtubules show increased stability with neuronal polarization. Stabilization of 
microtubules can be achieved by active stabilization of existing microtubules, increased 
polymerization, a reduction of microtubule destabilization and possibly microtubule bundling. 
Structural MAPs, MAP2 and tau, are highly expressed in the nervous system and regulate neurite 
formation, both of which acting as microtubule stabilizing proteins. MAP2 is one of the most 
conspicuous in the mammalian brain and its intracellular location has been shown to follow a 
developmentally specified program involving the main MAP2 isoforms. Namely, the low molecular 
weight isoform (65-70 kDa), MAP2c, a juvenile isoform that is downregulated after the early 
stages of neuronal development; and the high molecular weight isoforms (280 kDa), of which 
MAP2b is expressed both during development and adulthood, while MAP2a becomes expressed 
when MAP2c levels are falling and is not detected uniformly in all mature neurons. MAP2 has 
been extensively implicated in neuronal development and neurite outgrowth, not only due to its 
microtubule-stabilizing activity, but also due to its ability to bind F-actin and alter actin 
dynamics[14]. 
 Microtubule destabilizing proteins such as Op18/Stathmin has also been pointed has 
having a role in neuronal polarity[13]. Microtubule elongation is favoured by factors that bind 
α/β-tubulin heterodimers and increase polymerization, as for example CRMP-2, or by plus-end 
binding proteins (including APC, EB1, and EB3) that stabilize the dynamic plus-end. The inhibition 
of the microtubule destabilizer Stathmin via DOCK7, also increases microtubule stability[12]. 
The polarization of neurons involves a large incremental increase in surface area and 
volume, and thus membrane trafficking is required to support the development of polarity and 
neurite growth[3]. Furthermore, stage 3 axons contain synaptic vesicles and other axonal 
membrane associated proteins, indicating that organelles and other cytoplasmic components are 
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of neurons is, as mentioned above, attributed to the growth cone. The numerous extracellular 
ligands act through distinct receptors existing in the growth cone, promoting localized changes in 
filamentous actin in the growth cone which, in turn, direct microtubule dynamics and thereby the 
direction of axonal elongation[15]. Candidate proteins that have been shown to influence axonal 
and dendritic development include mainly neurotrophins, bone morphogenetic proteins (BMPs) 
and morphogens such as retinoic acid, semaphorins, and other more. 
Neurotrophins are an important family of neurotrophic factors that have complex 
influences on neuronal development[16]. This family is composed by the nerve growth factor 
(NGF), the brain-derived neurotrophic factor (BDNF), the neurotrophin-3 (NT-3), and the NT-4. 
Neurotrophins mediate their effects by binding to two types of cell surface receptors, the Trk 
tyrosine kinases (NGF binds to TrkA, BDNF and NT-4 bind to TrkB, and NT-3 binds to TrkC) and the 
p75 neurotrophin receptor (p75NTR). Interestingly, while Trk receptors transmit positive signals, 
p75NTR transmits both positive and negative signals and the signals generated by the two 
neurotrophin receptors can either augment or oppose each other[16-17]. 
In general, neurotrophins increase the dendritic complexity of pyramidal neurons by 
increasing total dendritic length, the number of branchpoints, and/or the number of primary 
dendrites[18]. BDNF was also shown to play an instructive role in axon specification, being this 
effect dependent on the activation of cAMP-dependent protein kinase (PKA) and phosphorylation 
of LKB1 by PKA[8-9].  NGF most studied effects, first established by Levi-Montalcini’s pioneering 
work, are its influence in neuronal survival and maintenance of growth cones for neurite 
extension, on sensory and sympathetic neurons. This NGF effect on growth cones is local, direct, 
rapid, and independent of communication with the cell body [2, 16]. Other growth factors have 
been shown to be involved somehow in neuronal polarization. This is the case of the basic 
fibroblast growth factor (bFGF), which accelerates the outgrowth of both axons and dendrites in 
hippocampal neurons[7], and insulin-like growth factor-1 (IGF-1) that functions as a neurotrophic 
factor regulating neurite growth in developing brain[3] and affects dendritic growth and 
branching of post-natal layer 2 cortical neurons[18]. 
Regarding BMPs, their mechanisms are varied and the various BMPs have differential 
effects on developing neurons. It was demonstrated that dendrite outgrowth in sympathetic 
neurons in culture requires the presence of BMP-2 or BMP-7, and possible the physiological 
source of BMPs may be the Schwann cells[19]. 
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Semaphorin 3A (Sema 3A), is involved in the regulation of asymmetric growth of cortical 
neurons by acting as a chemorepellant for axons and as chemoattractant for apical cortical 
dendrites[3, 8-9, 13]. 
Extracellular matrix proteins and adhesion molecules may also serve as extracellular 
signals, namely laminin or NgCAM. In fact, in dissociated cultures of hippocampal pyramidal 
neurons, the first immature neurite contacting a substrate interface of laminin or NgCAM is 
specified to become the axon. These results suggest that immature neurites can detect changes in 
the nature of the extracellular substrate regardless of the nature of the novel substrate they are 
encountering[3, 8]. 
Retinoic acid (RA) is a potent morphogen that functions as a locally synthesized 
differentiation factor for the developing nervous system[20]. It works by binding to nuclear 
receptors (hRAR), enhancing the interaction of these receptors with specific response elements 
(RAREs) located in the regulatory region of target genes, which culminates in the regulation of 
gene expression[21]. Because RA activates the early events of cell differentiation, which then 
induce context-specific differentiation programs, RA is considered a major differentiation 
factor[20].  
Growing evidences suggest that for specific subtypes of neurons the actions of some 
extracellular cues are remarkably slow, but may be profoundly potentiated by physiological levels 
of electrical activity[8]. Additionally, the outgrowth of axons and dendrites can also be 
differentially regulated by neurotransmitters; namely, glutamate has the ability to suppress 
dendrite elongation in cultured embryonic hippocampal neurons. On contrary, activation of GABA 
receptors can counteract the glutamate negative effect on dendritic outgrowth[7]. Integrins have 
also been implicated as extracellular cues relevant for neuronal polarization in hippocampal 
neurons[22]. 
1.2.4. Signaling networks in differentiation 
A multitude of neuronal polarity-regulating molecules have been revealed in the last few 
years. Various signaling molecules were proved to influence neuronal differentiation and 
polarization (further on summarized in Table 2). In the following text these signaling pathways are 
explained and contextualized in neuronal polarization. Noteworthy, many signaling networks 
operating in differentiation culminate in the regulation of actin and/or microtubule dynamics. 
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Rho-family of small GTPases: both Ras- and Rho-family small GTPases have been shown 
to be involved in axon specification and growth. At least ten types of Rho GTPases have been 
found in mammals, but the most extensively characterized comprises RhoA, Rac1 and Cdc42. The 
results of studies of Rho GTPases in neurons suggest that Rac1 and Cdc42 positively regulate axon 
growth thought the promotion of lamellipodia and filopodia formation in growth cones, while Rho 
acts as a negative regulator of neurite/axonal growth. So, it has been hypothesised that polarity-
inducing signals switch Rac/Cdc42 to their GTP-bound active states in the future axon (stage 2 
neurons), whereas Rho remains in its GDP-bound inactive state. In parallel, the other growth 
cones remain with GDP-bound inactive Cdc42/Rac, where the relatively high content of GTP-
bound active Rho inhibit those neurites elongation[15].  
The best characterized Rho effector is the Rho-kinase (ROK). ROK phosphorylates myosin 
phosphatase impeding it of dephosphorylating myosin light chain (MLC) of myosin II. Myosin II is 
then activated, thereby leading to contraction of actomyosin filaments, which promotes neurite 
retraction. Cdc42 is critical for axon formation, acting through N-WASP/Arp2/3 and p21-activated 
protein kinase (PAK) to regulate actin networks in the growth cone. The PAK pathway signals to 
the actin cytoskeleton via cofilin. The two main effector pathways involved in actin dynamics 
downstream of Rac1 are PAK and WAVE. Rac also inhibits the microtubule destabilizer 
Stathmin/Op18. Additionally, a Rac-specific guanine nucleotide exchange factor expressed in the 
nervous system, Tiam 1, has been show to regulate neurite growth[3, 13]. 
PI3-Kinase/Akt/GSK-3β pathway: several groups reported that local activation of PI3-
kinase, and the accumulation of phosphatidylinositol (3,4,5)-triphosphate (PIP3) at the tip of one 
of the immature neurites, is important for axon specification and elongation. PI3-kinase generates 
localized membranar sites enriched in PIP3, and such enrichment recruits the protein kinase Akt 
(also named protein kinase B) via its PH domain. Upon translocation, Akt is activated by dual 
phosphorylation on T308 and S473 by membrane-targeted protein kinase PKD1 and PKD2, 
respectively. Additionally, Integrin linked kinase (ILK) is also capable of increasing Akt activity by 
phosphorylation on S473. Activated forms of Akt are found enriched in growth cones of polarized 
neurons, and activated Akt and ILK phosphorylate constitutively active glycogen synthase kinase 3 
(GSK-3β), inactivating it. The decreased activity of GSK-3β is required for neuronal polarization. 
GSK-3 has multiple substrates that have the potential to regulate tubulin polymerization and 
microtubule stability, namely the microtubule plus-end binding proteins APC and CLASP2, CRMP-
2, which localizes to axon tips, and the microtubule associated proteins MAP1B and tau[8, 23]. 
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PTEN: the phosphatase and tensin homolog (PTEN) is a lipid and protein phosphatase that 
antagonizes PI3K signaling pathway, as PTEN dephosphorylates PIP3 into PIP2. Thus, increasing 
levels of PTEN leads to a loss of axon formation, whereas its reduction leads to a multiple axon 
phenotype. PTEN most likely works together with the PI3-kinase pathway to maintain the delicate 
balance of phospholipid composition at the membrane to ensure proper neuronal polarization 
and axon formation[8]. 
LKB1, SAD-A/B, and MARKs: LKB1 translocates from the nucleus and is activated by 
binding to its necessary coactivator Strad and by being phosphorylated by PKA and p90RSK kinase. 
Once activated, LKB1 phosphorylates SAD-A/B kinases and potentially the microtubule affinity-
regulated kinases, MARK1-4. SAD (and MARK kinases), in turn, target and phosphorylate several 
MAPs, reducing their microtubule binding affinity[8]. 
RAS/RAF/MEK/ERK pathway: several studies in vitro support an important promoting 
function of this pathway in axon growth. This pathway seems to regulate axonal cytoskeleton via 
phosphorylation of several MAPS, and also regulates a broad range of transcription factors, 
including SRF[8]. 
CRMP-2: Experimental research in hippocampal neurons shown that CRMP-2 is involved 
in the regulation of axon formation during neuronal polarization, in addition to its role as a 
mediator of semaphorin-induced growth cone collapse. Apparently, CRMP-2 regulates 
microtubule dynamics by binding to tubulin heterodimers, and given the enriched localization of 
this protein in the growing axon, it can be speculated that CRMP-2/tubulin complexes locally 
change the rate of microtubule assembly, and thereby contribute to axonal growth[3, 23]. 
Calcium: Calcium (Ca2+) is a second messenger and a well established key mediator of 
neurite outgrowth regulation, in almost all types of neurons. It can act directly, or through the 
activation of various calcium-binding proteins to modulate the state of polymerization of actin 
filaments and microtubules, and thus differentially regulate growth cone motility (filopodia 
behaviour) and neurite elongation. A calcium-sensitive phosphatase, calcineurin, has also been 
implicated in the establishment of neuronal polarity. Furthermore, Ca2+ can activate the protein 
gelsolin that can cleave actin filaments[7]. Supporting all these findings, in vivo imaging studies 
have provided direct evidence for a negative relationship between the frequency of spontaneous 
Ca2+ transients and the rate of axon outgrowth[8] 
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Table 2. Signaling molecules with a role in neuronal polarization[3, 7-9, 13]. 
Signalling Molecule Methodology Applied Effect on Neuronal Polarization Ref. 
Rho GTPases 
Treatment of neurons with 
Clostridium difficile toxin B. 
Induction of multiple axons, 
shows fewer filopodia and 
lamellipodia. 
[24] 
Rho A 
Constitutively active form of 
RhoA and overexpression of 
RhoA proteins. 
Inhibits neuritogenesis. 
[25-27] 
Dominant-negative form. Enhances neurite outgrowth. [26] 
Cdc42 
Hippocampal Cdc42-knockout 
neurons. 
Defects in actin cytoskeleton, 
fail to form filopodia, and lack 
axons. 
[28] Dominant-active or dominant-
negative Cdc42 ectopic 
expression in Drosophila 
sensory neurons. 
Inhibits the growth of both 
axon and dendrites. 
Rac 1 
Dominant-active or dominant-
negative Rac 1 ectopic 
expression in Drosophila 
sensory neurons. 
Inhibits axonal growth but it 
does not affect dendritic 
development. 
[28-31] 
Dominant-active Rac in mouse 
Purkinje cells. 
Specifically affects axonal 
growth but not dendritic 
growth. 
[28] 
Specific ablation from the 
cortex. 
Does not influence axon 
growth, rather influence axon 
guidance  
[32-34] 
siRNA knockout of mammalian 
Rac1. 
Does no affect axon identity. 
[34] 
Constitutively active version of 
Rac1 in cultured neurons. 
Does not affect axon 
specification. 
[26] 
Rho-kinase 
Dominant-negative ROK. Inhibits the LPA-induced neurite 
retraction. [35] 
Dominant-active ROK. Induces neurite retraction. 
N-WASP 
Dominant-negative N-WASP in 
PC12 cells. 
Inhibits the NGF-induced 
neurite formation. 
[36] 
Tiam1 
Overexpression in hippocampal 
neurons. 
Induces multiple axons. 
[37] 
Antisense oligonucleotides. Inhibits axon formation. 
PI3K 
Pharmacologic inhibition using 
LY294002 or Wortmannin. 
Prevents axon formation. 
[38-41] 
Overexpression of the 
constitutively active catalytic 
subunit of PI3K (p110α). 
Leads to the formation of 
multiple axons. [41] 
Akt or PKB 
Overexpression of  
myristoylated Akt. 
Multiple axons. 
[41] 
RNAi or pharmacologic 
inhibition. 
Failure of axon formation. 
 
PTEN 
Increased levels of PTEN 
expression. 
Loss of axon formation. 
[38-39] 
RNAi-mediated knockdown. Multiple axon phenotype. [38] 
GSK-3 
Use of several types of GSK-3 
inhibitors. 
Formation of multiple axons. [38, 42-
44] 
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Signalling Molecule Methodology Applied Effect on Neuronal Polarization Ref. 
Double knockin-mice bearing 
single point mutations in GSK-
3β (S9A) and GSK-3α (S21A). 
No obvious deficits in neuronal 
morphogenesis in vivo and in 
vitro. 
[43] 
CRMP-2 
Overexpression. Multiple axons. 
[45] 
Expression of truncated forms. Impair axon formation. 
APC Expression of truncated forms Inhibit axon formation. [46-47] 
LKB1 
Genetic deletion in cortical 
pyramidal neurons. 
Prevents axon formation. 
[48-50] 
Overexpression. Multiple axons. 
SAD kinases 
RNAi knockdown. Partially abrogates the ability of 
LKB1 overactivation to induce 
the formation of multiple axons 
in cortical neurons. 
[49] 
Double knockout mice for SAD-
A and SAD-B. 
Neurons incapable of forming 
axons in vivo.  
[51] 
Overexpression of SAD-A/B. Induces a modest but 
significant increase in multiple 
axon formation. 
[52] 
MARK2 
RNAi-mediated knockdown. Induces supernumerary axons 
[53] 
Overexpression. Inhibits axon formation. 
MEK 
Use of pharmacological 
inhibitors: PD98059 and U0126. 
Striking inhibition of axon 
growth. 
[54] 
RAS/RAF/MEK/ERK 
pathway 
Studies of gain and loss of 
function. 
Strong axon promoting 
function. 
[55] 
Calcium 
Exposure of neurons to Ca
2+
 
ionophore. 
The neurons don’t form an axon 
and only form minor processes. 
[56] 
Focal application of Ca
2+
 
channel blocker nifedipine to a 
minor process. 
Greatly increase the probability 
of that process becoming the 
axon. 
Focal application of 
Cytochalasin D to a minor 
process. 
Induced that process to become 
the axon. 
 
1.3. The Amyloid-β Precursor Protein (APP) 
Amyloid Precursor Protein (APP) is an ubiquitously expressed type 1 membrane protein 
that suffers proteolytic cleavages and, as its name implies, is the precursor protein of the amyloid 
β-peptide (Aβ), the main component of brain senile plaques, characteristic of Alzheimer disease.  
 APP is widely expressed on the cell surface, particularly in neurons, and has been 
implicated in roles such as cell adherence, survival, migration and differentiation. Recently, it is 
being established as a neuromodulator of developing and mature nervous system. APP 
phosphorylation might be important in APP-mediated neuronal differentiation, possible by 
altering APP traffic, by increasing APP cleavage to its physiological fragments, and/or by increasing 
the binding of APP to specific signal transducers.   
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1.3.1. APP characterization and gene family 
In 1986 the gene encoding APP was identified [57-60], and found to be located on the 
Down´s syndrome region of the chromosome 21 (21q21.2-3)[57]. The human APP gene contains 
19 exons and is expressed in many cell and tissue types including endothelial, glia and neurons of 
the brain[61]. APP is one of 3 members of a small gene family that, in humans, includes APLP1 and 
APLP2. All encode type 1 integral membrane glycoproteins with a large extracellular domain and a 
short cytoplasmic region. These three functional and structurally related proteins are well 
conserved in evolution and share similar functions, but only APP contains the Aβ domain, 
encoded by parts of exons 16 and 17 [62-63]. 
1.3.2. APP isoforms and functional domains 
APP has eight isoforms derived from alternative splicing of its 19-exon gene, which are 
expressed in a cell-type specific manner and differ only in the size of their extracellular sequence. 
The three major isoforms are: APP 695, APP 751, and APP 770 (illustrated in  
Figure 7). All of these transcripts encode multidomain proteins with a single membrane-
spanning region. APP 751 and APP 770 contain the exon 7, which encodes a serine protease 
inhibitor (also called Kunitz proteinase inhibitor (KPI)) domain, missing in APP 695[64]. 
 
 
Figure 7. Schematic representation of the 19-exon APP gene and its three major isoforms produced by alternative 
splicing. Reproduced from the reference[63]. 
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thymocytes (OX-2 domain). More or less in the middle of the extracellular domain lies a putative 
growth-promoting motif called “RERMS” (residues 403-407 of APP 770), followed by a gelateinase 
A inhibitor (residues 407-417), a collagen binding site (residues 523-540), and the Aβ sequence. 
The Aβ domain comprises the 28 residues just outside the membrane plus the first 12-14 residues 
of the transmembrane domain (amino acids 700-723). The Aβ sequence contains additionally zinc, 
cooper and heparin binding sites, and a RHDS motif (amino acids 5-8 of Aβ) that appears to 
promote cell adhesion[64, 68-69]. Furthermore, the cytoplasmic region of APP contains a 
681GYENPTY687 motif containing an NPXpY internalization signal for membrane proteins[70].  
1.3.3. APP cellular localization and intracellular trafficking 
APP is an transmembranar protein that is dynamically sorted through the membranes of 
intracellular organelles and the plasma membrane[71]. The major pathways of APP and its 
proteolytic derivates include anterograde, retrograde and transcytotic transports (Figure 9)[72]. 
 
Figure 9. Intracellular trafficking of APP. 1. Constitutive secretory pathway: nascent APP molecules reach the cell 
surface; 2. Internalization; 3. Trafficking through endocytic and recycling compartments back to the cell surface or 
degraded in lysosome. Reproduced from reference [73]. 
 
APP is cotranslationally translocated into the endoplasmic reticulum via its signal peptide, 
and then post-translationally modified (“matured”) through the secretory pathway. Its acquisition 
of N- and O-linked sugars occurs rapidly after biosynthesis, and its half-life is relatively brief. Both 
during and after its trafficking through the secretory pathway, APP can undergo a variety of 
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proteolytic cleavages, specified in the subsequent topic[64]. In neurons, APP is subjected to the 
constitutive secretory pathway and undergoes fast axonal transport to presynaptic terminals. 
After arrival at the cell surface, APP suffers internalization, via its YENPTY motif, being delivered to 
the endosomes (retrograde transport). From the late endosomes, APP is either transported to 
lysosomes, or recycled by transport vesicles to the trans-Golgi network (TGN) and to the cell 
surface[72]. 
APP is transported via the clathrin coat complex, which are involved in two main sorting 
routes: the endocytic pathway, connecting the cell surface to the endosome, and the pathway 
connecting the TGN to the endosome. APP contains the NPXY amino acid motif, which governs 
the targeting of cargo to clathrin-coated vesicles. A number of families of clathrin adaptor 
proteins have been found to mediate the binding of the APP’s NPXY motif to clathrin coats and 
therefore serve as regulators of APP endocytosis: autosomal-recessive hypercholesterolemia 
(ARH) protein, disable family member (Dab) 1, c-Jun N-terminal kinase interaction (Jip1b) protein, 
members of the Fe65 and of the X11 families, in particular X11a (Figure 8, bottom panel)[71].  
The retromer is the second coat complex implicated in the transport of APP and its β-
secretase BACE. It is a coat complex composed of vacuolar protein sorting (VPS) 35, VPS26, VPS29, 
VSP5, and VPS17. VPS35 represents the core of the retromer complex, binding to other retromer 
elements, and also binding the cytoplasmic tail of the transmembrane protein cargo that is being 
sorted. sorLA is a type-1 transmembrane molecule that is sorted by the neuronal retromer. As it 
binds APP and BACE, sorLA might function as the equivalent of an adaptor protein, binding the 
retromer complex to cargo proteins such as APP[71].  
The fusion of transport vesicles to the membrane of the targeted organelle completes the 
process of transmembrane protein sorting. The fusion event is governed by three main families of 
proteins: the SNAREs, Rab, and Sec1/Munc18. The SNAREs expressed in the membrane of the 
transport vesicle interact with a single SNARE protein in the membrane of the organelle, with Rab 
and SM mediating this interaction[71].   
1.3.4. APP proteolytic processing 
As described above, part of the newly synthesized APP undergoes fast axonal transport in 
the secretory pathway, being targeted as a full-length protein into axons. A fraction of the full-
length APP reaches the plasma membrane, is incorporated in endocytic vesicles, re-enters the cell 
and undergoes endoproteolytic cleavages by proteases, releasing biologically active peptides. Two 
main proteolytic cleavage sites have been identified close to the membranar domain, and one site 
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occurs within the transmembranar domain. Starting from the amino terminus of the protein, 
these are termed β (between residues 596 and 597 of APP695), α (between residues 596 and 597 
of APP695) and γ (711-712 or 713-714) cleavage sites. Each cleavage is catalyzed by separate 
enzymes: β-, α- and γ-secretases, respectively[68]. The cellular distribution of APP secretases 
seems to be restricted to specific cellular compartments. 
 The α- and β-cleavages are mutually exclusive events, with APP undergoing two post-
translational processing pathways. In the non-amyloidogenic pathway, APP is cleaved within the 
Aβ region by the α-secretase, liberating a large soluble extracellular N-terminal fragment - sAPPα.  
The carboxy-terminal fragment (CTF), named C83, remains tethered to the membrane, and is 
subsequently subjected to a transmembrane cleavage by γ-secretase, producing a non-pathogenic 
p3 peptide and the cytoplasmic APP intracellular C-terminal domain, AICD. In the alternative, 
amyloidogenic pathway, APP is first cleaved by β-secretase, generating the large soluble sAPPβ 
peptide and the CTF C99. This is subsequently processed by γ-secretase, producing the Aβ peptide 
associated with Alzheimer’s disease (that has two predominant forms differing in their C-
terminals length, Aβ40 and Aβ42), and the intracellular AICD fragment [63]. Figure 10 is a 
schematic representation of the APP cleavage sites and its principal proteolytic products.  
 
 
Figure 10.Schematic diagram of APP proteolytic processing. Cleavage by α-secretase enables the secretion of sAPPα 
into the medium and the preservation of the C83 fragment in the membrane. The C83 fragment can undergo cleavage 
by γ-secretase to release the p3 peptides and AICD (right side). Alternatively, proteolytic cleavage by β-secretase results 
in the secretion of the slightly truncated sAPPβ molecule and the retention of the C99 fragment. The C99 fragment can 
also undergo cleavage by γ-secretase to release the Aβ peptides and AICD (on the left). Reproduced from reference[74]. 
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α-secretases: several membrane-bound disintregrin and zinc metalloproteinases including 
ADAM17 (or TACE), ADAM10, ADAM9 and MDC-9 have been identified has having α-secretase-
like activity. Cleavage of APP by activation of α-secretase is a constitutive, relatively major and 
ubiquitous pathway of APP metabolism in most cells, and precludes the generation of intact 
Aβ[63, 73]. These proteins are synthesized as preproproteins, and to become active their 
prodomain is cleaved in the late Golgi by proprotein convertases (PPCs)[68]. The aspartyl protease 
β-site APP-cleavage enzyme (BACE) 2 has also been identified has a α-secretase, as it can cleave 
APP in the middle of the Aβ domain, between Phe19 and Phe20.  Importantly, activation of PKC 
by phorbol esters upregulates the α-cleavage pathway, and the same occurs with estrogen, 
testosterone, various neurotransmitters and growth factors [63, 73]. 
β-secretases: β-cleavage is attributed to two enzymes, named the β-site APP-cleavage 
enzymes BACE1 and BACE2. Both enzymes are expressed in neural tissues, but experiments using 
BACE1 knockout mice strongly indicate that BACE1 is the major β-secretase in the brain. BACE1 is 
produced as a pro-enzyme in the ER and the in the nuclear envelop, and its prodomain is cleaved 
by furin or other PPCs just before trafficking through the Golgi[63, 68]. Mature BACE is mainly 
found in the endosome, and in lower levels in the cell surface and TGN, with virtually no mature 
BACE being found in the lysosome or endoplasmic reticulum. Thus, β-cleavage may occur in any of 
the cellular sites where mature BACE1 is found, but since the endocytic pathway is the most 
acidic, it is thought to be the best suitable subcellular location for BACE activity[71]. Supporting 
this, studies of BACE-APP interaction using FRET analysis showed that APP binds BACE with 
greatest efficiency in the endosome, less in the cell surface, and to a negligible degree in the TGN 
and secretory pathway[75]. 
γ-secretases: γ-secretase is a multimeric complex, made of four essential subunits: 
Presenilin-1 or -2, Nicastrin, APH-1, and PEN-2[76]. Each subunit has been found necessary for the 
enzymatic activity of the complex, which is dramatically impaired when any of the components 
are deficient[77]. Aph-1 and Nicastrin initially form a subcomplex to bind and stabilize Presenilin, 
and Pen-2 confers the gamma-secretase activity by facilitating Presenilin endoproteolysis[76]. 
Besides being consider a scaffolding protein within the γ-secretase complex, Nicastrin has been 
shown to act as γ-secretase receptor as it binds APP (and Notch) through its ectodmain[78].  
Strong evidence suggests that the γ-secretase complex cleavages APP mainly in the TGN 
and early endosomal locations[79]. The complex acts in multiple sites within the APP 
transmembrane domain, cleaving the remaining APP CTFs inside the membrane. APP αCTF (or 
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CTF83) cleavage yields AICD and p3 fragment production, and βCTFs (CTF99 or 89) processing 
results in different Aβ forms and AICD[80]. The γ-secretase complex acts through a mechanism 
known as regulated intramembrane proteolysis (RIP), that besides a proteolytic process, 
comprises a transcriptional regulation event following translocation to the nucleus[80]. Very 
interestingly, it has been suggested that the origin of APP CTFs, either from the β- or α-secretase 
processings, may determine the affinity of γ-secretase to the CTFs[80]. Of note, in addition to 
cleaving APP CTFs, γ-secretase cleaves other several functionally important membrane proteins, 
like Notch, cadherin, tyrosinase, ErbB4, CD44, etc[77]. 
1.3.5. Phosphorylation of APP 
Direct phosphorylation of the APP molecule may have important roles in the regulation of 
APP binding, traffic and processing. Indeed, APP is a phosphoprotein with several putative 
phosphorylation sites. Two of that residues shown to be phosphorylated, Ser198 and Ser206, are 
localized in the APP ectodomain. In addition, the APP cytoplasmic tail comprises three Tyr 
residues and five Ser/Thr putative phosphorylation sites: Thr654, Tyr653, Ser655, Thr668, Ser675, Tyr682, 
Thr686 and Tyr687, most of which are located within three functional motifs: 653YTSI656, 667VTPEER672, 
and 682YENPTY687 [81-82]. However, there is still some controversy concerning which residues are 
actually phosphorylated in vivo [81-82]. 
Phosphorylation of Ser655, that has been observed to occur in mature APP molecules in 
vitro and in vivo [83-85], may be a pivotal regulatory process for APP trafficking and proteolysis, 
since this residue is located in the basolateral sorting motif, 653YTSI656, and it is the only APP 
Ser/Thr residue phosphorylated by PKC. Additionally, NMR analysis showed that APP 
phosphorylation at S655 induces significant local conformational changes in the APP C-terminus at 
and downstream the 653YTSI656 motif[86]. Besides PKC, Ser655 maybe be phosphorylated by 
calmodulin-dependent protein kinase II (CaMKII)[87], and by APP kinase I[88].  
Preliminary work from the Neuroscience laboratory of the Center for Cell Biology research 
unit suggest that APP phosphorylated at S655 is an active molecule, crucial in the regulation of 
the APP subcellular trafficking. Though the use of APP S655 phosphomutants - serine 655 to 
alanine (S655A), and serine 655 to glutamate (S655E), mimicking unphosphorylated and 
phosphorylated APP, respectively – evidence was gather that S655 phosphorylation of mature 
APP molecules is a signal for APP traffic via the secretory pathway, facilitating its incorporation 
into TGN vesicles and Golgi exit. S655A is thus highly retained at the Golgi, exhibits delayed 
incorporation into secretory post-TGN vesicles, and delayed sAPPα medium secretion. In contrast, 
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S655E appear to have facilitated Golgi exit, enhanced traffic between the Golgi and PM as well as 
a higher rate of sAPPα secretion. Furthermore, another study from the Neuroscience laboratory 
showed that S655 phosphorylation enhances mature APP half-life by increasing APP binding to 
the retromer complex and the subsequent retromer-mediated APP retrieval to the TGN, thus 
increasing APP recycling[89]. These raises the hypothesis that part of the mature APP population 
is phosphorylated at S655 when it is necessary to target APP for a more dynamic TGN-to-PM 
trafficking, and sAPPα generation, what may occur through the catalytic action of PKC[90].  
1.4. Potential role for the Amyloid-β Precursor Protein as a modulator 
of neuronal differentiation 
APP is a very complex molecule that is now proved to be determinant for neural function, 
as either in its full-length configuration, or in its resulting proteolytic fragments. Furthermore, it 
has been proposed that not only the accumulation of Aβ, but also reductions in the level or 
activity of certain APP fragments play a critical role in the cognitive dysfunction characteristic of 
Alzheimer´s Disease. 
Various studies currently address the physiological roles of APP and its fragments, 
gathering growing evidence of its implication in development and cell growth, intercellular 
communication, signal transduction, nuclear signaling, and structural and functional plasticity. 
Three APP products have received particular attention, the sAPPα, Aβ and the AICD. Secreted 
APPα is neuroprotective, neurotrophic, and regulates cell excitability, calcium homeostasis, and 
synaptic plasticity, therefore potentially regulating learning and memory, while Aβ appears to 
exert opposing effects[91]. The intracellular carboxyterminal fragments of APP also deserve 
attention due to their ability to bind several proteins, most of which being adaptor proteins that 
can bind other components to exert their effects. Particularly, AICD possesses transcriptional 
regulatory activity when in complexes with other proteins, such as the ternary complex composed 
by AICD, the adaptor protein Fe65 and acetyl-transferase TIP60. Noteworthy, that is little 
consensus and several conflicting findings regarding the AICD-dependent regulated genes, with 
candidate target genes being: APP itself, KAI1, a tumor suppressor and antimetastasis gene; 
neprilysin, a neutral endopeptidase with Aβ-degrading activity; LRP1; the EGF receptor; GSK-3β, a 
kinase involved in tau phosphorylation; Transgelin, an actin cross-linking protein. Furthermore, 
AICD has been shown to contribute to apoptosis, development, synaptic plasticity and 
cytoskeletal dynamics[80]. 
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Despite its numerous potential roles in neural functions, here we will mainly focus the 
potential role of APP in neurite outgrowth and neuronal differentiation. 
APP preferential localizes at nerve terminals, where it is supposed to play a role in 
establishing or maintaining cell-cell contacts[92]. During early development, APP is present in 
growing neurites of neonatal rat brain[93], and developing neurons undergo increased APP 
expression, with this protein being preferentially localized in the neuritic growth cones [94]. 
The first evidences that APP was involved in neurite outgrowth came from the findings 
that antibodies against APP specifically diminished the effects of NGF on neurite length and 
branching in pheochromocytoma PC12 cells, indicating that APP mediates neuritic outgrowth 
promotion by NGF [95], and from a study using human neuroblastoma La-N-1 cells stably 
expressing an antisense APP mRNA, which exhibited a 30% reduction in cell proliferation, reduced 
cell adhesion, and 2-4 fold increases in neurite-bearing cells[96]. Noteworthy, the cell adhesion- 
and neurite outgrowth-promoting roles of APP appear to be correlated, what is not surprising as 
neuronal migration, neurite outgrowth, and even synaptogenesis involve substrate adhesion[73]. 
The expression of APP695, the major APP neuronal isoform, is developmentally regulated 
during the differentiation of hippocampal neurons and neuronal-like cell lines in vitro. 
Interestingly, despite the fetal neuronal cells express higher levels of APP, they show little 
secretory processing into its soluble derivative, suggesting that the principal functional role in 
central nervous system development is responsibility of APP membrane-bound holoprotein[97]. 
Consistent with that were the results obtained by Qui et al (1995) when using a system in which 
developing neurons were grown on transfected non-neuronal cells expressing various isoforms of 
APP, to be able to distinguish the functional properties of cell surface APP from those of soluble 
APP and Aβ peptides. Results demonstrated that neurite outgrowth from hippocampal neurons 
was promoted by increased surface-expressed APP but not by increased sAPP and other secreted 
derivatives in the medium. In addition, they were able to prove that surface-expressed APP770 
and APP751 isoforms (APP isoforms containing the KPI domain) promote neurite outgrowth more 
vigorously than APP695, most probably due to their higher roles in cell adhesion, mediated by the 
APP ectodomain [98]. In this same year, Alliquant et al. reported that a 6, 18, and 24h block in APP 
expression using antisense oligonucleotides was sufficient to produce significant inhibitory effects 
on neurite growth of primary cortical neurons. APP antisense-induced inhibition of neurite growth 
affected all neurites, both axonal and dendritic, without changing size or pattern of cell bodies 
spreading on the substratum, suggesting that the effects on neurite growth were not caused by a 
global change in cell-substratum adhesion[99]. A previous study had demonstrated that the 
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binding of APP to specific proteoglycan species of heparin sulfate proteoglycans (HSPGs), a 
component of the extracellular matrix, is an important step in the regulation of neurite 
outgrowth. Moreover, the study established that APP must be substrate-bound in vitro to exert 
its physiological effects, since when added to the cultures in soluble form, APP did no stimulate 
neurite outgrowth as efficiently. Noteworthy, APP appeared to inhibit the action of laminin on 
neurite outgrowth, suggesting a dynamic role in altering the general adhesiveness of the 
environment[100].  
A couple years later, an experience was performed exploiting the differences in neuron 
survival and development between hippocampal neurons deriving from wild-type and APP-
deficient mice. These were co-cultured with astrocytes from wild-type or APP-deficient mice, to 
allowed determining the effects of APP secretory products. The APP-deficient neurons showed 
markedly shorter axons at 1 day in vitro (DIV), but the APP-deficient neurons grown with wild-
type astrocytes ultimately developed axons equal in length to those of wild-type neurons, 
implying that APP primarily contributes to the onset of axon formation. Moreover, wild-type 
neurons always had more branched neurites and ultimately had more minor processes than did 
APP-deficient hippocampal neurons. By 3 DIV, wild-type and APP-deficient neurons co-cultured 
with wild-type astrocytes had significantly shorter axons than neurons co-cultured with APP-
deficient astrocytes, while the number of minor processes and the number of branch points were 
significantly greater. Data indicated that both cell-associated APP and secreted APP products 
appear to be important for normal neuronal development, with cell-associated APP enhancing 
neuron survival, the timely initiation of axon growth, and axon arborization, whereas APP 
secreted products appear to modulate neuronal polarization limiting the growth of axons and 
enhancing dendritic growth[101]. 
More recent data suggests that full-length APP acts in a cell autonomous manner to 
promote neurite outgrowth, both in vitro and in vivo. sAPPα addition to neurons was known to 
stimulate neurite outgrowth, but only recently it was shown that sAPPα does not stimulate 
neurite outgrowth in the absence of cell surface APP. Furthermore, and corroborating several 
previous evidences suggesting a functional interaction between APP and integrins to mediate 
neurite outgrowth, this study showed that sAPPα competes with full-length APP for binding to 
integrin β1 (Itgβ1), in this way inhibiting the ability of APP to regulate Itgβ1-induced neurite 
outgrowth, and explaining why APP-deficient neurons had longer neurites that could not be 
further elongated by sAPP addition. APP and Itgβ1 appear to directly interact via APP ectodomain, 
but can also indirectly interact via Fe65, to which both proteins bind [102]. Indeed, a study where 
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interaction-deficient FE65 was introduced via adenovirus into cultured hippocampal neurons, 
showed that a complex including APP, FE65 and an additional protein (most probably MENA, the 
mammalian homolog of the Drosophila enabled protein) is involved in neurite outgrowth at early 
stages of neuronal development. Although the FE65 mutants did not affect total neurite output, 
they decreased axon segment length and slowing of axonal growth cones, apparently by altering 
the local formation of the complex [103]. 
In addition to NGF and HSPGs, induction of APP expression by RA has been described in a 
number of cell lines of neuronal and non neuronal origin [104]. Furthermore, all members of the 
APP family are up-regulated in parallel with neurite extension upon differentiation of human 
neuroblastoma SH-SY5Y cells with RA (further discussed in the following subtopic). A synergistic 
effect on neurite generation between RA, BDNF and APP synthesis has also been reported[105].  
Regarding the effects of APP phosphorylation (pAPP) in neuronal differentiation, Ando et 
al (1999) explored the function of Thr668 pAPP in PC12 cells differentiation. They demonstrated 
that APP is phosphorylated at Thr668 when cells start to elaborate processes, and increases with 
neuronal differentiation, being mainly localized in growth cones. In the same study, they also 
reported that this role in neurite extension was independent of sAPP generation[106]. 
Besides full-length APP and sAPPα, AICD was also related to neuronal differentiation. 
Most recently, some authors correlated increased AICD levels with suppression of NGF-induced 
PC12 differentiation[107]. It appears that AICD interferes with Ntrk1 receptor signalling, and that 
elevated AICDs signalling to the nucleus downregulates p53 and cyclinD and suppresses STAT3 
phosphorylation (an activator of transcription), potentially enhancing cell proliferation and 
inhibiting neuronal differentiation[107]. Such results corroborate with previous studies in an in 
vivo mouse model using TAG1, a functional ligand of APP that increases AICD production and 
simultaneously leads to low neurogenesis[108]. Mechanistically, the role of AICD in neurite 
development may involve its binding to the actin regulatory protein MENA (the mammalian 
homolog of the Drosophila enabled protein), mediated by Fe65, potential influencing actin 
remodelling and cytoskeleton dynamics[109].  
1.4.1. Expression and processing of Amyloid-β Precursor Protein in retinoic 
acid-differentiated human SH-SY5Y cell line 
Besides PC12 cells and primary neurons, several studies focusing APP role in 
differentiation have been performed in the neuroblastoma SH-SY5Y cell line. Nonetheless, data 
concerning the differentiation days at which APP protein levels increase in the RA-differentiated 
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SH-SY5Y cells are contradictory. König and colleagues (1990) were the first to study the expression 
of the APP gene in neuronal differentiation using 10 µM RA-induced SH-SY5Y differentiated cells, 
reporting a marked increase in total APP mRNA that peaked at differentiation day 4. Furthermore, 
they observed alterations in the spliced pattern of the APP transcripts, in favour of the APP695 
mRNA, associated with an increase of total APP gene expression[110]. Contrarily, Beckman and 
Iverfeldt (1997), reported a smaller fold induction of the APP mRNA expression even after 6 days 
of differentiation, under the same differentiation conditions[111]. Later, Ruiz-León and Pascual 
(2003), accomplish morphologic differentiation of SH-SY5Y cells and a strong reduction of the 
cellular proliferation after 4 days of treatment with only 1 µM RA.  In this study, a similar increase 
of APP-mRNA levels was observed after 4-6 days of treatment with 1 µM RA as by Beckman and 
Iverfeldf using 10 µM RA. In addition, the authors did not observe any alterations in the isoforms 
pattern, but reported a generalized and significant increase of both full-length and secreted APP 
[104]. Very intriguing were the results published by Murray and Igwe (2003), which induced SH-
SY5Y neuronal phenotype with different RA concentrations and found no statistically significant 
changes in total APP mRNA and protein expression. However, when analyzing the different APP 
transcripts, they observed an increase in the expression of the APP695 mRNA transcript with 
increased RA concentration, and suggested that it is this increased APP695 transcript that supports 
a neuronal phenotype in RA-treated SH-SY5Y cells[112]. In one last study by Holback and 
colleagues (2005), a 3-fold increase was obtained for APP in SH-SY5Y cells after 6 days of 
incubation with 10 µM RA (in agreement with Beckman and Iverfeldt results), and increased 
sAPPα and AICD levels [105]. 
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Table 3. Alterations in APP expression and APP proteolysis to sAPP and AICD in RA-differentiated SH-SY5Y cells. Dif: differentiation. PAD: gene coding for the APP; Signif: significantly. 
Treatment 
APP mRNA 
APP prot 
 
sAPPα AICD C99 
Morphological changes 
Total 695 751/770 
R
A
 
1
 
µ
M
 
4 d 
 
↑ ≈ 2-fold[104]; 
No change (but a 
change in 
profile)[112]. 
 
 
↑ from 20% to 
34% of total 
APP 
mRNA[112]. 
 
No change[112]. 
General ↑ of 
intracellular 
APP [104];  
No 
change[112]. 
General ↑ 
[104]. 
  ↓↓ cell prolifera^on and 
morphologic dif ≈ 10µM 
RA [104]; 
Elongated and slender cell 
bodies, and enhanced 
neuritogenesis [112]. 
 
R
A
 
1
0
 
µ
M
 
3d ↑≈2-fold [111]. 
      Intense neurite extension 
and proliferation arrest 
[111]. 
4 d 
↑ 10.2-fold [110]; 
No quantitative 
change (but a slight 
increase)[112]. 
↑ 10-fold [110]; 
↑  from 20% to 
≈40% of total 
APP 
mRNA[112]. 
APP751 ↑ 9.5-fold and 
APP770 ↑ 12-fold [110]; 
No change[112]. 
 
No 
change[112]. 
   Neuronal-like 
phenotype[110]; 
≈ 1µM but to a much 
greater extense[112]. 
6 d ↑ 3-fold [111].   ↑ 3-fold [105]. 
↑ 4-fold 
[105]. 
↑4-fold 
[105]. 
No change 
[105]. 
Marked dif with longer 
neuritis[110]. 
8 d 
 
↑ from 54% to 
70%  of total 
PAD transcripts 
[110]. 
APP751 ↑ 6-fold(↓ from 
37,5% to 26,5  of total 
APP mRNA) and APP770: ↑ 
3.4-fold  (↓ from 8.5% to 
3,5%  of total APP 
mRNA)[110]; 
    
More slender and longer 
bipolar morphology[110]; 
9 d 
   No signif ↑ 
[105]. 
↑ 7-fold 
[105]. 
No further 
↑[105]. 
↓ ≈50% 
[105]. 
 
6d + 
BDNF 
   No signif 
↑[105] 
↑ 1.7-fold 
over 6d[105]. 
 
↓≈75% [105].  
9d + 
BDNF 
   
Signif ↑[105].  
↑ 1.7-fold 
over 9d[105]. 
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2. Aims 
In the present work it will be addressed the ability of APP and APP phosphorylated at 
S655 to mediate neuronal differentiation, namely morphogenic and neuritogenic processes. To 
this end, the well documented cell model of SH-SY5Y neuroblastoma cells will be used, under RA-
differentiation conditions or undifferentiated, together with several molecular tools. 
2.1. General Aims 
 
i. To evaluate the effects of APP overexpression in retinoic acid (RA)-induced neuronal-like 
differentiation; 
ii. To study the effect of APP phosphorylation at S655 (mimicked by APP S655 
phosphomutants) in RA-induced neuronal-like differentiation;  
iii. To determine if APP alone can induce morphologic alterations related to neuronal-like 
differentiation, and the influence of APP S655 phosphorylation in this process; 
iv. To determine the role of AICD in regulating mechanisms underlying neuronal-like 
differentiation; 
2.2. Specific Aims.  
 
i. To optimize SH-SY5Y cells transfection with Wt, S655A and S655E APP-GFP cDNA 
constructs. These mutants mimic, to some extent, APP dephosphorylated and 
phosphorylated state at the S655 cytoplasmic residue, respectively; 
ii. To optimize conditions of differentiation of SH-SY5Y non-transfected and transfected 
cells; 
iii. To test if APP overexpression influences RA-mediated SH-SY5Y differentiation, by 
transfecting cells with Wt APP-GFP cDNA at the second day of RA-induced differentiation; 
iv. To test if the APP S655 phosphomutants can differentially affect SH-SY5Y differentiation, 
by transfecting cells with S655A and S655E APP-GFP cDNAs at the second day of retinoic 
acid (RA)-induced differentiation; 
v. To record morphologic and neuritogenic alterations in non-differentiated SH-SY5Y cells 
transfected with Wt, S655A, and S655E APP-GFP cDNAs for 24 and 48h, and to analyze the 
role of AICD in these mechanisms, by incubating cells with a drug inhibitor of AICD 
production in the last 24h of the 48h time point. 
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3. Methods 
3.1. Culture, growth and maintenance of SH-SY5Y cell line 
SH-SY5Y human neuroblastoma cells are originally derived from the cell line SK-N-SH, 
established from a bone marrow biopsy of a neuroblastoma patient. The SH-SY5Y cell line is 
maintained in 10% foetal bovine serum (FBS) minimal essential medium (MEM):F12 (1:1), with 2 
mM L-glutamine and 100 U/mL penicillin and 100 mg/mL streptomycin [10 mL 
Streptomycin/Penicilin/Amphotericin solution, Gibco], in a 5% CO2 humidified incubator at 37°C. 
Cells were split when at 70-80% confluent. 
3.2. Trypan Blue assay for initial cell plating 
In order to plate a defined number of living cells, a dye exclusion assay was used, in which 
living cells with an intact cytoplasmic membrane exclude the reagent, while dead cells stain blue 
due to dye incorporation through permeabilized damaged cytoplasmic membranes. To an aliquot 
(90 μL) of cells suspension, 10 μL of 0,4% Trypan Blue were added and incubated for 1 minute at 
room temperature. The unstained (viable) cells were counted in a hemacytometer, and cell 
concentration calculated for further cell plating. 
3.3. Transient transfection of the cell lines with APP-GFP cDNAs 
In order to study the role of APP and APP phosphorylation in differentiation, Wt, S655A 
and S655E APP695-GFP cDNAs were used. S655A and S655E mimic an APP S655 constitutive 
dephosphorylated and phosphorylated states, respectively. To optimize SH-SY5Y cells transfection 
with the Wt and S655 APP-GFP cDNAs, two different transfection methods were initially tested, 
the Calcium phosphate and the TurboFectTM lipid-mediated methods. 
3.3.1. Transfection of coprecipitates of calcium phosphate and DNA (CaP) 
followed by a glycerol shock 
Calcium phosphate-mediated transfection is a widely used method, and its efficiency can 
be increased by incorporating a glycerol shock in its procedure. Three hours before transfection 
the appropriate medium was replaced, and for each monolayer of cells to transfect two tubes 
were prepared. A first tube containing 1 μg of the respective DNA and 6,2 μL of 2M CaCl2 was 
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prepared and final volume adjusted to 50 μL with sterilized H2O; a second tube containing 50 μL 
of HEPES-buffered saline (HBS) 2x was also prepared, to which the DNA solution was added 
dropwise with gentle mixing. The mixture was incubated for 20-30 minutes at room temperature, 
after what it is vortexed and immediately transferred, dropwise, into the medium above the cell 
monolayer, with gentle rock of the six-well plate. Transfected cells were incubated for 12 hours at 
37ºC in a humidified incubator in an atmosphere of 5% CO2, after which were subjected to 
glycerol treatment. Briefly, growth medium was removed by aspiration, and 1,5 mL of 15% 
glycerol in 1x HBS added to the monolayer. Cells were incubated for 30 seconds, the glycerol 
removed by aspiration, and the monolayers washed twice with PBS. New medium was added, and 
the cells further incubated for 36 hours, after which cells and cell medium were collected in 1% 
SDS and 10% SDS, respectively, for Western blotting (WB). 
3.3.2. Transfection by the TurboFectTM reagent 
Transfections were carried out according to the manufacter´s instructions (Fermentas Life 
Sciences). Briefly, for each monolayer of cells grown in 6-well plates, 2 μg of DNA were diluted in 
100 μL of serum-free growth medium. After being briefly vortexed, 2 μL of TurboFectTM were 
added to the diluted DNA. Of note, the amounts of DNA and TurboFectTM were scaled-up based 
on preliminary optimization assays. The mixture was vortexed and incubated for 15-20 minutes at 
room temperature, after what this mixture was added dropwise, to each well, with gentle rocking 
of the plate to achieve even distribution. Cells were further incubated for 5-48h at 37º C in a CO2 
incubator. This time period was further optimized to no more than 12h of incubation after which 
medium had to be changed, and transfection was left to occur for a total of 24 or 48h. This was 
the transfection method selected for the experimental assays (see Results). 
 
3.4. Wt and S655 Phosphomutants APP-GFP cDNAs 
APP isoformAPP isoform 695 (APP695) cDNA was used as template to generate S655 
cDNA point mutations, namely Serine 655 to Alanine (S655A) or to Glutamate (S655E), using site-
directed mutagenesis[90, 113] . These two amino acids, due to their size and charge, mimic a 
constitutively dephosphorylated and phosphorylated S655 residue, respectively. To engineer the 
APP695-GFP cDNA constructs (APP-GFP), the stop codons of Wt and S655 phosphomutants 
APP695 cDNAs were removed by PCR using specifically designed primers. The resultant fragments 
were digested with endonucleases (AgeI and NruI) and subcloned into the  AgeI/SmaI  restriction 
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sites of the GFP-encoding mammalian expression vector (pEGFP-N1, Clontech) as N-terminal  APP-
GFP translational fusions. The nucleotide sequences of the APP695 phosphorylation cDNA point 
mutants and the open reading frames were confirmed by DNA sequencing (ABI PRISM 310 genetic 
Analyser, Applied Biosystems). 
3.5. Differentiation of the SH-SY5Y cell line  
For the differentiation optimization assays, SH-SY5Y cells were differentiated by 
incubation with 1/10 µM RA in 1/10% FBS medium for four days, with RA being added every other 
day, and cell medium replaced at that time. The initial cell density plated was assigned after a 
previous optimization, accordingly to the FBS/RA combination. When differentiation was carried 
out on 10% FBS, initial cell density used was 1,0x104 cell/cm2, independently of the RA 
concentration used. For a combination of 1% FBS/1 μM RA, or 1% FBS/10 μM RA, cells were 
seeded at a density of 3,0x104 cell/cm2, or 6,0x104 cell/cm2, respectively. For the experimental 
assay, the 10 μM RA/10% FBS combination was used, and cells were plated at 1,0x104 cell/cm2. 
3.6. Cells treatment with N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-S-
phenylglycine t-Butyl Ester (DAPT) 
Non-differentiated SH-SY5Y cells were incubated with 1 μM DAPT[114] (InSolutionTM γ-
Secretase Inhibitor IX, Calbiochem), in the previous 24h before being harvested. In summary, 0,5 
μL of DAPT were diluted in 12 μL DMEM, serum and antibiotics/antimycotics-free. From this first 
solution, 6 μL were transferred and diluted in 6 mL of complete medium in order to prepare the 
work solution, which was added to the cells for 24h at 2 mL/six-well. 
3.7. Cell collection and quantification of protein content (BCA) 
Cells’ conditioned medium was collected with 1/10 v/v 10% boiling SDS, cells washed with 
PBS, and further harvested with 1% boiling SDS. Cell and media lysates were boiled for 10 min, 
and cell lysates sonicated for 30 sec. Total protein measurements were performed in an aliquot of 
the cell lysates using Pierce’s BCA protein assay kit, following the manufacturer’s instructions. This 
method combines the reduction of Cu2+ to Cu+ by protein in an alkaline medium with a sensitive 
colorimetric detection of the Cu+ cation using a reagent containing bicinchoninic acid. The first 
reaction step is the biuret reaction in which peptides containing three or more amino acid 
residues form a colored chelate complex with cupric ions in an alkaline environment containing 
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sodium potassium tartrate; BCA addition is the second step. Chelation of two molecules of BCA 
with one Cu+ ion gives origin to a purple-coloured reaction product, a water-soluble complex with 
a strong absorbance at 562 nm that is linear with increasing protein concentration over a working 
range of 20-2000 µg/ml. Total protein concentration of each sample was determined through a 
standard curve prepared by plotting BSA absorbance vs. BSA standard concentration. Briefly, 
microtubes with standard protein concentrations were prepared as in Table 4. 
 
Table 4. Standards used in the BCA protein assay method. BSA, Bovine serum albumin solution (2 mg/ml). 
Standard BSA (µl) 10% SDS (µl) H2O (µl) Protein mass (µg) W.R. (ml) 
P0 - 5 45 0 1 
P1 1 5 44 2 1 
P2 2 5 43 4 1 
P3 5 5 40 10 1 
P4 10 5 35 20 1 
P5 20 5 25 40 1 
A microtube was prepared per sample, to be assayed with 5 µl of each sample plus 45 µl 
of the solution in which the sample was collected (1% SDS). 1 ml of working reagent (W.R.; 
mixture of BCA reagent A with BCA reagent B in the proportion of 50:1) was rapidly added to all 
microtubes (standards and samples) and these incubated at 37 ºC exactly for 30 min. Tubes were 
coolled to RT and their absorbance at 562 nm was immediately measured. 
3.8. Antibodies 
The primary antibodies used in this study were the antibody 22C11 (Chemicon) directed 
against APP N-terminus, recognizing full-length APP and secreted APP (sAPP), and the antibody 
CT695 that recognizes APP C-terminal (detection of APP full length and APP C-terminal peptides), 
for APP and APP-GFP detection. To evaluate neuritogenic-related cytoskeleton alterations, the 
monoclonal anti-acetylated α-tubulin (Sigma), the polyclonal anti-actin N-terminal antibody 
(Sigma) that recognizes epitope(s) in the N-terminal domain of actin reacting with all actin 
isoforms, the monoclonal anti-MAP-2 antibody clone HM2 (Sigma) directed against all known 
MAP-2 isoforms. To investigate possible AICD transactivated genes the following antibodies were 
used: polyclonal anti-Glycogen Synthase Kinase-3 (GSK-3) that recognizes the alpha (~51 KDa) and 
beta (~46 KDa) isoforms; the polyclonal anti-KAI 1 (C-16, Santa Cruz Biotechnology) directed 
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against the human KAI1 C-terminus, and the polyclonal anti-Transgelin (H-75, Santa Cruz 
Biotechnology) raised against a region near the N-terminus of human Transgelin (H-75, Santa Cruz 
Biotechnology). As potential internal standards for Western blot assays, the monoclonal 
antibodies anti-β-Tubulin, that binds the two major and a minor β-tubulin isotypes, and anti-
Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) clone 6C5 (Ambion) that detects this 
ubiquitous glycolytic enzyme, were used. A list of all the antibodies used with their respective 
dilutions and secondary antibodies is depicted in Table 5. 
 
Table 5. Antibodies used in the Immunoblots, respective target proteins and specific dilutions used. All the secondary 
antibodies are from Amersham Pharmacia. 
Target 
Protein/Epitope 
Primary Antibody Secondary Antibody 
Acetylated Tubulin 
Anti-Acetylated Tubulin 
clone 6-11B-1 (Sigma) 
Horseradish Peroxidase conjugated α-Mouse IgG 
Dilution: 1:5000 
Actin 
Anti-Actin N-terminal 
(Sigma) 
Dilution: 1:1000 
Horseradish Peroxidase conjugated α-Rabbit IgG 
Dilution: 1:5000 
APP N-terminal 
22C11 (Chemicon) 
Dilution: 1:250 
Horseradish Peroxidase conjugated α-Mouse IgG 
Dilution: 1:5000 
APP C-terminal 
CT695 (Invitrogen) 
Dilution: 1:500 
Horseradish Peroxidase conjugated α-Rabbit IgG 
Dilution: 1:5000 
GAPDH 
Anti-GAPDH clone 6C5 
(Ambion) 
Dilution:  
Horseradish Peroxidase conjugated α-Mouse IgG 
Dilution: 1:5000 
GSK-3 β 
Anti-GSK-3 total 
(Chemicon) 
Dilution: 1:500 
Horseradish Peroxidase conjugated α-Rabbit IgG 
Dilution: 1:5000 
EGFP 
JL.8 (Clontech) 
Dilution: 1:1000 
Horseradish Peroxidase conjugated α-Mouse IgG 
Dilution: 1:5000 
KAI-1 
Anti-KAI 1 (C-16)  
(Santa Cruz Biotechnology) 
Dilution: 1:500 
Horseradish Peroxidase conjugated α-Rabbit IgG 
Dilution: 1:5000 
MAP-2 
Anti-MAP-2 clone HM2 
(Sigma) 
Dilution: 1:1000 
Horseradish Peroxidase conjugated α-Mouse IgG 
Dilution: 1:5000 
Transgelin 
Anti-transgelin (H-75)  
(Santa Cruz Biotechnology) 
Dilution: 1:200 
Horseradish Peroxidase conjugated α-Rabbit IgG 
Dilution: 1:5000 
β-Tubulin 
2-28-33 (Invitrogen) 
Dilution: 1:2000 
Horseradish Peroxidase conjugated α-Mouse IgG 
Dilution: 1:5000 
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3.9. Western Blot Assay 
Mass-normalized cell aliquots were subjected to electrophoresis on a 7,5/10% 
(optimization assays) and 5-20% gradient (experimental assays) sodium dodecylsulfate (SDS) 
polyacrylamide gel, being subsequently transferred to nitrocellulose filters. After proteins 
electrotransfer, membranes were initially soaped in 1X TBS or 1x PBS for 10 min. Blocking of 
possible non-specific binding sites of the primary antibody was performed by immersing the 
membrane in 5% non-fat dry milk in 1X TBST solution for 1-2 h. Further incubation with primary 
antibody was carried out for a period of time accordingly to the manufactures instructions 
(ranging from 2 h to overnight incubation). After three washes with 1X TBS-T or 1X PBS-T, of 10 
min each, the membrane was further incubated with the appropriate secondary antibody for 2 h 
with agitation. All primary and secondary antibodies used were diluted (specific dilutions in Table 
5), accordingly to the manufactures instructions, in 1X TBS-T/3% non-fat dry milk, 1X TBS/1% BSA 
or 1X PSB-T/3% non-fat dry milk. Membranes were additional washed three times with 1X TBST or 
1X PBS-T, before being submitted to the ECLTM (enhanced chemiluminescence; GE Healthcare) 
detection method, a light emitting non-radioactive method for detection of immobilised specific 
antigens, conjugated directly or indirectly with horseradish peroxidase-labelled antibodies. 
Washed membranes were incubated for 1 min at RT with the ECL detection solution or for 5 min 
with the ECL+ solution, freshly prepared fresh following the manufacturer’s instructions. ECL/ECL+ 
detection solution in excess was drained. In a dark room, an autoradiography film was placed on 
the top of the membrane, inside a film cassette. The cassette was closed and the blot exposed for 
an appropriate period of time. The film was then removed and developed in a developing solution 
(Sigma Aldrich) washed in water, and fixed in a fixing solution (Sigma Aldrich). The blot was 
further washed in TBS-T and distilled water before drying, for better conservation. 
3.10. F-actin detection, Fluorescence Microscopy and 
Morphological analyses 
Cells grown on coverslips were fixed with a 4% paraformaldehyde PBS solution for 30 min 
(or with iced acetone when to analyse the cytoskeleton) and permeabilized with a 0,2% TRITON 
PBS solution (10 min). After three washes, coverslips were directly mounted on microscope slides 
with Fluoroguard Antifading Reagent (Bio-Rad).  
In order to visualize F-actin, 2 μL Alexa Fluor 568 Phalloidin was diluted in 100 μL PBS 1% 
BSA and added to coverslips for two hours in the dark at 37 ºC. Coverslips were further washed 
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three times with PBS and one last time with distilled water, and then mounted with the antifading 
reagent on microscope glass slides for further epifluorescence microscopy analysis.  
Epifluorescence microscopy was carried out using an Olympus IX-81 motorized inverted 
microscope equipped with a LCPlanFl 20x/0.40 objective lens. Cell counts and neurite length were 
measured using two image analyzer softwares: AnalySIS (Olympus) and ImageJ. Processes 
counting were divided in: all processes arising from a cell, counts of pre-neurites (processes 
longer than 20 μm), and counts of differentiated neurites (processes longer than two times the 
cell body length, 35 μm)[115]. Cells were considered differentiated when possessing at least one 
differentiated neurite.  
3.11. Data analysis 
Autoradiograms resulting from blots immunodetection were scanned in a GS-710 
calibrated imaging densitometer (Bio-Rad) and protein bands quantified using the Quantity One 
densitometry software (Bio-Rad). Data are expressed as mean ± SEM (standard error of the mean) 
of three independent experiments. Statistical significance analysis was conducted by one way 
analysis of variance (ANOVA) followed by the Tukey test. 
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4. Results 
4.1. Optimization of the transfection method
 
In order to optimize SH
Cells were plated at a cell density of 1,75x10
and Wt APP-GFP cDNAs, using t
glycerol shock, and the TurboFect
by Immunoblot analysis using an
the TurboFectTM methods yield 
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transfection rate, it was associated 
shown). Therefore, in all subsequent 
 
Figure 11. Immunoblot analysis of 
calcium-phosphate mediated transfection; Turb: TurboFect
N1: cells transfected with vector EGFP
detect a) APP-GFP 695 immature; b) APP
APP 751/770 mature forms. 
 
4.2. Establishment of SH
 
Secondly, an experiment was delineated in 
foetal bovine serum/retinoic acid (FBS/RA) for SH
transfected but also in transfected cells, since transfection itself can potentially be an insult for 
cells, and APP may induce cell death[115]. Cells were differentiated for four days using different 
FBS/RA conditions, being transfected at the second day with the EGFP
Since the levels of RA and FBS affect cell proliferation and cell death, conditi
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1/10% FBS medium were used in combination with different initial cell densities, previously 
optimized. When differentiation was carried out in 10% FBS, cells were plated at 1,0x104 
cells/cm2 due to their higher proliferation. When using 1% FBS/1 μM RA, cells were seeded at 
3,0x104 cells/cm2, and for 1% FBS/10 μM RA cells were seeded at 6,0x104 cells/cm2, due to 
increased cell death. Following four days of differentiation, transfection was visually observed in 
an epifluorescence microscope, and cells were harvested for immunoblot analyses. First, APP-GFP 
transfection was confirmed by immunoblot analyses (Figure 12). 
 
APP-GFP transfection (bands a,b) was confirmed for all RA/FBS conditions, by immunoblot 
analysis either using the 22C11 antibody, against APP N-terminus, or the CT695 antibody, against 
the APP C-terminus (Figure 12). Of note, APP-GFP transfection appears to increase intracellular 
sAPP (22C11-positive and CT695-negative bands, marked with an asterisk). Further, as expected, 
the levels of endogenous APP generally increased in differentiated versus non-differentiated cells 
(compare NT lanes of Dif 1 and Dif2 with Cnd1; Dif 3 and Dif 4 with Cnd2). Only the APP levels of 
the Dif2 NT lane appear to be anomaly low, as it will be denoted to occur for other proteins, 
indicating that an experimental error probably occurred when loading this sample. 
The protein levels of acetylated α-tubulin, a known parameter of differentiation that 
indirectly measures microtubules stabilization [115-117], were analysed to first evaluate cellular 
differentiation in the conditions tested. The levels of the putative housekeepings proteins β-
Tubulin and GAPDH, potential internal standards for western blot analyses, were also monitored 
(Figure 12 lower panel). In this initial differentiation period (first 4 days), acetylated tubulin levels 
increased in 1 μM RA conditions (Dif1, Dif3), while maintaining in 10 μM RA conditions (Dif4; 
again in Dif2 NT lane it appears that an error occurred when loading the sample). Remarkably, in 
all conditions tested, acetylated α-tubulin always decreased with transfection, and more markedly 
for APP-GFP transfection. Further and somewhat expected, in all the RA/FBS conditions tested, β-
Tubulin followed similar variations to the acetylated α-tubulin ones, and its levels increased with 
cellular differentiation but generally decreased with Wt APP-GFP transfection. Unexpectedly 
though, GAPDH levels suffered fluctuations with different RA/FBS differentiation conditions, but 
again decreasing with APP-GFP transfection in all conditions (compare Wt APP-GFP with N1 values 
at the same condition). In conclusion, nor β-Tubulin nor GAPDH can be used as control invariant 
proteins (β-Tubulin can even be used as a differentiation cytoskeleton-related marker), and we 
are currently still in the process of finding a good housekeeping protein to use in differentiation 
and transfection conditions. 
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Figure 12. Evaluation of APP-GFP expression and of the variation of acetylated α
different differentiation conditions and APP
4 days with different RA and serum conditions and transfected at the second day with wild type APP
and Cnd 2: control non-differentiated cells initially plated at 2,0x104/cm2 (control of Dif1 and Dif
(control of Dif3 and Dif4), respectively; NT: non
Confirmation of APP cDNA transfection using 22C11 and anti
immature; b) APP-GFP 695 mature; c) and d), endogenous immature and mature APP 751/770, respectively; 
intracellular sAPP is marked with an asterisk. Lower panel and graph: Protein expression profiles of acetylated α
Tubulin, β-Tubulin and GAPDH with different RA/FBS
and GAPDH quantitative data are presented as fold increases over control non
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Figure 13. Morphological analysis of SHSY
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compare conditions of equal RA concentration but increased FBS% - Dif 3 with Dif1). However, 
when only considering the population of N1 and APP-GFP expressing cells, cellular differentiation 
only increased with the FSB concentration (from Dif3 to Dif1; from Dif4 to Dif2). That is, increased 
RA concentration led to a decrease in the percentage of differentiated transfected cells and, 
remarkably, N1 and Wt APP-GFP expressing cells in condition Dif4 did not present any neurites. 
When considering both transfected and non-transfected populations, conditions of 10% FBS 
resulted in higher percentages of cellular differentiation, being condition Dif2 the one where this 
parameter is more homogeneous. In terms of neuritic length (Figure 13-B), at this early 
differentiation period the FBS/RA combination seems not to be very important, since the values 
did not suffer marked variations. The same occurred when expressing APP-GFP, which only 
induced a small increase in the length of longer neurites at condition Dif1. 
In synthesis, the morphometric data suggests that 10% FBS conditions are preferable to 
study differentiation of transfected cells, since FBS appears to be protective at higher RA 
concentrations, where cells tend to die. The 10 μM RA/10% FBS combination led to high levels of 
differentiation and rendered the most homogeneous results in terms of transfected and non-
transfected cells differentiation. Interestingly, both the immunoblot data and the morphometric 
data already indicated that Wt APP-GFP expression was not leading to higher SH-SY5Y 
differentiation, but rather doing the opposite, and this was further studied in more detail.  
 
4.3. Effects of APP overexpression and APP S655 phosphorylation on 
RA-induced differentiation  
 
Previous studies on APP in neuritogenesis, that used RA differentiated SH-SY5Y cells, all 
reported an increase in APP levels after 3-4 days of differentiation, indicating that APP is 
important in the early period of differentiation. The effects of APP overexpression, and of 
mimicking APP S655 dephosphorylation (S655A) and phosphorylation (S655E), were thus further 
evaluated in this early period of differentiation. For that, cells were differentiated for 4 days in 
10% FBS/10 μM RA medium, being transfected with wild-type and S655 phosphomutant APP-GFP 
cDNAs (Wt, S655A, S655E) at the second day of differentiation. Transfection was conducted for 
48h in order to allow morphological alterations dependent of genic transcription to occur.  
APP-GFP transfection, APP and sAPP protein levels, and the protein levels of some 
neuritogenic cytoskeleton-related markers, were evaluated by immunoblot analyses.  
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Figure 14. Effects of Wt, S655A and S655E 
neuritogenic markers. Immunoblot analysis of SH
and transfected at the second day with 
acetylated tubulin with APP-GFP transfection.
with the 22C11 antibody. Bottom graph presents the sAPP/APP ratio and the acetylated tubulin fold increase over N1 
transfected cells values. B. Variation of MAP
all MAP-2 isoforms. ND: Control non-differe
S655A and S655E APP-GFP tranfected cells
proteins relative transfection rates. *p<0.05; **p<0.
 SACS/UA, 2011
APP-GFP transfection in sAPP/APP ratios and in microtubule
-SY5Y cells differentiated for 4 days in 10% FBS/10 
Wt, S655A and S655E APP-GFP cDNAs. A. Variation of sAPP/APP ratio and 
 Cellular APP and sAPP secreted into conditioned medium were detected 
-2 with APP-GFP transfection. A MAP-2 antibody was used 
ntiated cells; N1: vector EGFP-N1 transfected cells; Wt, SA and SE
, respectively. All data was normalized to Tubulin levels 
01; ***p<0.001. n= 3. 
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From the immunoblot results and graph quantifications (Figure 14) one can see that the 
sAPP/APP ratio decreases for Wt APP-GFP transfected cells (~0.7), in comparison with N1 
transfection levels. This ratio was even lower for S655A transfected cells, but was higher for S655E 
cells (~N1 sAPP/APP ratio). Wt APP-GFP transfection also decreased α-tubulin acetylation by 
~50%, in agreement with what was previously observed in the differentiation optimization assay. 
The APP S655 phosphomutants decreased even more acetylated tubulin levels (Figure 14-A) to 
around ~30% of N1 values. A second differentiation marker was tested, MAP-2, a microtubule-
binding and stabilizing protein that has been described to participate in neuritic outgrowth [14, 
116-117]. A decrease was also observed for the levels of the high molecular weight MAP-2a/b 
isoforms (Figure 14-B) with APP-GFP transfection, especially for the S655 phosphomutants. The 
levels of MAP-2c/d, the main MAP-2 isoforms in SHSY-5Y cells, only slightly decreased with Wt 
APP-GFP transfection, and suffered no significant alterations between the APP-GFP proteins. A 
similar variation pattern was observed for another MAP-2 positive band of ~50KDa, named ‘MAP-
2 fragment’, which potentially results from MAP-2 degradation. Altogether these results show 
that Wt and especially both S655 APP phosphomutants decrease microtubules stability (lower 
levels of acetylated tubulin and of MAP-2 isoforms).  
 
The morphometric parameters of the cellular population were also analysed, to 
characterize the effects of Wt and S655 phosphomutants APP-GFP transfection in SH-SY5Y 
differentiation. Since APP-GFP transfection and cells exposure to RA may result in cell death, as 
previously observed, the cellular viability was first evaluated by scoring the number of live and 
dead cells in microphotographs (Figure 15-A and B). Results show that APP-GFP transfection 
indeed decreased the number of cells, relatively to EGFP-N1 expressing cells. Such decrease was 
more pronounced for the APP phosphomutants, which appeared to be able to induce cell death 
also on neighbour non-transfected cells (Figure 15-B). Regarding the neuritogenic output, cells 
expressing Wt and S655A APP-GFP had a lower percentage of cells with processes and neurites 
than the N1 cells, resulting in lower percentage of differentiated cells (cells with at least one 
neurite longer than 35 μm). However, S655E APP-GFP transfection resulted in similar levels of 
cells with processes as for N1, and was able to induce higher percentages of differentiated cells, 
either in S655E transfected cells or in the general population (Figure 15-C). Of note, the observed 
higher cell death for the general population, upon S655A and S655E transfection, may contribute 
to their high levels of differentiated cells, simply by liberating more space for differentiation to 
occur.  
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Figure 15. Morphological analysis of SHSY
GFP cDNAs. N1 pop: population of EGFP
S655A, and S655E APP-GFP. A. Percentage of living cells.
percentages of the number of cells in the EGFP
the percentage of dead cells on the coverslips 
of cells with processes and neurites. Percentage
and neurites), and > 35 μm (differentiated neurites)
and neurites (>35 μm) was measured. 
 
 
With respect to neuritic length, the phosphomimicking mutant also increased the 
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neuritogenesis and neurite elongation are related to rearrangements on both microtubules and 
actin cytoskeletons, F-actin organization was
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Figure 16. Analysis of F-Actin rearragments
a drug that selectively labels actin filamen
N1 EGFP and Wt, S655A, S655E APP
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stabilization of stress fibers was more affected, as these cells shown higher number of 
intermediate and cortical cells (Figure 16-B). S655E APP-GFP also affected stability of actin fibers 
but to a lower extent, presenting a lower decrease in the percentage of cells with stress fibers. 
The type of F-actin distribution was further analysed in the population of transfected cells that 
presented an elongated differentiated morphology (Figure 16-C). Results obtained suggest that 
initial depolimerization and further stabilization of stress fibers seem to be both important in 
neurite outgrowth, since these are the two major phenotypes found in elongated differentiated 
cells expressing S655E, the APP-GFP protein previously observed to induce increased neuritic 
length (Figure 15-B).   
Altogether, these data led us to conclude that APP-GFP transfection for 48h, upon 2 days 
of RA-incubation, induced more detrimental than positive effects on differentiation, especially in 
terms of generation of protruding processes. This could be related to the overall destabilization of 
the microtubular and actin cytoskeletons. Nonetheless, mimicking S655 phosphorylation (S655E 
mutant) had a positive effect in neuritic length, most probably related to its higher sAPP/APP ratio 
and its ability to lead to more moderated F-actin fibers destabilization.  
Several factors could contribute to these results. As previously observed in the 
optimization of differentiation assays, cells transfection appears to be detrimental to cells 
incubated with RA. Further, while APP positive effects on differentiation may be mediated by full-
length APP and the sAPP fragment, negative effects could be mediated by the AICD fragment, 
who has been related to cytoskeleton dynamics[118]. Therefore we decided to further evaluate if 
APP itself could induce morphologic alterations relevant for the differentiation process, in the 
absence of any morphogen such as RA, and to better understand the role of APP phosphorylation 
at S655 in these alterations. In addition, by using pharmacologic tools we assessed the role played 
by the AICD fragment in these alterations. 
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4.4. Phosphorylation
morphological changes
 
In order to study the ability of APP to
alterations, and to even trigger cell differentiation in the absence of a morphogen such as RA, 
non-differentiated SH-SY5Y cells were transfe
GFP cDNA for 24 and 48h. The S655A and S655E APP
with the Wt to address the influence of S655 phosphorylation in these
analyse the role of AICD in these mechanisms, 
secretase inhibitor that blocks 
Several morphological and morphometric analysis were performed to characterize each 
condition. The effects of APP-
 
Figure 17. Quantification of cell density and cell death upon 24 and 48h of N1, Wt, S655A and S655E transfection
1 µM DAPT incubation. A. Number of
24h (taken as 100%) B. Percentage of tr
transfected cells were score in epifluorescence microphotographs, for each condition.
 
All APP-GFP proteins decreased cell density by 
values, and cell density generally decreased with time
DAPT. In comparison, the percentage of transfected dead cells was only ~10% higher for A
expressing cells than for N1 cells at 24h. Cell death did not change
increased by about 20% for all APP
death for N1 or APP-GFP transfected cells. Since the per
decrease in cell density, one can infer that APP 
not the main fragment responsible for those effects.
and plastic cells was scored in ep
 
-dependent APP- and AICD-mediated 
 
 induce differentiation-related morphologic 
cted with the N1-EGFP vector and with the Wt APP
-GFP cDNAs were transfected side
 changes
cells were incubated with 1 μ
AICD production, in the last 24h of the 48h time point.
GFP transfection on cell density and cell death were first evaluated.
 transfected living cells per mm
2
, expressed as percentage over the N1 values at 
ansfected dead cells in the transfected cells population.
 
~30-50% (24h) in comparison with N1 
 for all transfectants, not being reverted by
 with time for vector N1, but 
-GFP expressing cells. In addition, DAPT did not affect cell 
centage of cell death is not as high as the 
also decreases cell proliferation
 Following, the presence of cuboid
ifluorescence microphotographs (Figure 18). 
- 63 - 
-
-by-side 
. To specifically 
M DAPT, a gamma-
  
 
 
 and 
 On average 100-200 
 
PP-GFP 
, and that AICD is 
, elongated 
- 64 - 
 
Joana Fernandes da Rocha 
Figure 18. Epifluorescence and phase contrast microphotographs of non
N1 and APP-GFP cDNAs for 24 and 48h, in the presence or absence of DAPT.
 SACS/UA, 2011
-differentiated SH-SY5Y cells transfected with 
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Figure 19. Evaluation of SH-SY5Y c
S655E APP-GFP cDNAs, in the presence or absence of DA
cells; Wt, S655A, S655E: APP-GFP tranfected cells
 
Regarding cell morphology (Figure 18 and Figure 19), at 24h all APP
had increased elongated and plastic morphologies over cubo
phosphorylation appears to favour elongation of the cell body, while S655A expression also led to 
elongated cells but with more rounded cell bodies (Figure 18). With time in culture N1 population 
tended to elongate to the expense of cuboid morphology. In contrast, APP
tended to decrease elongated morphology to more cuboid shapes. Interestingly, DAPT reverted 
part of this effect, but turned elongated cells more plastic, especially for the S655 mutants
Figure 18). This also occurred for some N1 elongated cells exposed to DAPT, but S655A and S655E 
cells were generally more plastic and less symmetric than Wt or N1 expressing cells.
 Since morphologic alterations depend on actin cytoskeleton alteratio
lamellipodia was scored as a parameter of actin dynamics (Figure 20).
 
 
Figure 20. Quantification of the number of 
cells with lamellipodia features upon 24 and 
48h transfection with N1 vector, Wt, and 
S655A and S655E APP-GFP cDNAs, in the 
presence or absence of DAPT in the last 24h 
of the 48h time point. N1: vector EGFP
transfected cells; Wt, S655A, S655E: APP
tranfected cells. 
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Results obtained show that the percentage of cells with lamellipodia increase
of transfection. However, expression of all APP
at 24h (about 2-fold increase over N1 values), with S655E showing the highest effect. Incubation 
with DAPT did not affect the increase in the num
From the epifluorescence microphotographs it could be denoted that APP
was able to increase neuritogenesis in some cells, and actually trigger cellular differentiation in 
the absence of a morphogene such as R
assayed using several parameters. First, the percentage of cells with pr
in development, > 20 μm, were scored, and their mean length measured (Figure 21
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Morphometric analysis of 
presence or absence of DAPT. N1: vect
Percentage of cells with pre-neurites (processes 
process higher than 20 μm was calculated. 
μm was calculated. C. Number of processes per cell.
20 μm (‘> 20 μm’) and neurites (processes longer than 35 
 SACS/UA, 2011
-GFP proteins highly increased lamellipodia already 
ber of lamellipodia (Figure 20). 
A. Neuritogenesis and neuritic elongation were therefore 
e-neurites, that is neurites 
SH-SY5Y cells transfected with the APP-GFP cDNAs for 24 
or EGFP-N1 transfected cells; Wt, S655A, S655E: APP-GFP tran
> 20 μm). The percentage of transfected cells bearing at least one 
B. Mean pre-neurites length. The mean length of processes 
 All processes arising from a cell (‘processes’), processes longer that 
μm, ‘>35 μm’) were considered. 
 
d with time 
-GFP expression 
-A and B) 
and 48h, in the 
sfected cells. A. 
greater than 20 
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Concerning the ability of APP cDNAs to trigger SH
APP-GFP expression greatly increased the number of cells beari
comparison with the N1 vector alone (
length at 24h (Figure 21-B), with S655E being the most efficient in this process and 
higher percentage of cells with neurites. Interestingly, while with time in culture (48h) the 
percentage of N1 expressing cells with pre
GFP transfected cells. This effect was completely 
increase the number of N1 cells with pre
observed. After 48 hours of transfection, APP
AICD-dependent manner, since it was greatly reverted by DAPT (
The number of all processes and neurites (pre
scored, and expressed as number per cell 
number of processes and neurites at 24h, with S655A being more efficient in 
protruding processes, while S655E appears more efficient in elongating the processes (high 
number of pre-neurites and highest number of neurites). Again, while for N1 these numbers 
increased at 48h, for APP-GFP expressing cells the number of processes decreased
AICD appears to be involved in this inhibition of neuritogenesis, since this
by DAPT incubation, with the number of all processes even surpassing the control ones. 
In addition, the number of secondary neurites was also quantified
Figure 22) and, although very few and almost only present in APP
results showed that APP-GFP 
phosphomutant being the mo
obtained with DAPT incubation (~1.4 fold increase), suggesting that AICD 
generation of secondary processes
Figure 22. Number of secondary neurites 
48h, in the presence or absence of DAPT in the last 24h of the 48h time period.
 
-SY5Y cell neuritogenesis (
ng pre-
Figure 21-A). Further, APP-GFP also increased neuritic 
-neurites increased, this percentage decreased in APP
reverted by DAPT, what was even able to further 
-neurites. Regarding neuritic length, a similar effect was 
-GFP induced neuritic retraction,
Figure 21-B).
-neurites, and neurites > 35 μm) was also 
(Figure 21-C). APP-GFP remarkably increased the 
 effect is totally reverted 
 ( 
-GFP transfected cells, 
was able to induce neuritic ramification, with the S655A 
st efficient. An increase in secondary processes could be further 
. 
 
per cell in SH-SY5Y cells transfected with the APP
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The role potentially played by the APP and its proteolytic products sAPP and AICD was 
further evaluated in this experiment
subjected to SDS-PAGE. The rates of APP
were analysed by Western blot, together with the 
genes, and cytoskeleton proteins. In addition, two other samples were ran side
evaluate the effects of sAPP in these
with vector N1-EGFP alone but incubated in the last 24h of transfection
medium, derived from an extra set of Wt APP
 
 
Figure 23. Immunoblot analysis of non
GFP cDNAs and treated or not with 1μM
antibodies against APP C-terminus, to evaluate APP
GSK-3β, KAI-1, and against β-tubulin. 
 SACS/UA, 2011
. Cells treated as above were collected and cells lysates 
-GFP transfection and production of CTFs and AICD
protein expression of putative AICD target 
 proteins expression. These corresponded to cells transfected 
 with sAPP
-GFP transfected cells.  
-differentiated SH-SY5Y cells transfected with the Wt, S655A and S655E APP
 DAPT. 24h, 48h, hours of APP-GFP transfection. Cell lysates were probed with 
-GFP and CTFs-GFP levels, and against actin, transgel
 
-GFP 
-by-side to 
-enriched 
 
-
in (TAGLN), 
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Figure 24. Quantification of the effects of Wt, S655A and S655E APP
(A.) and GSK-3β (B.) protein expression levels
24h (taken as 1.0), upon correction to the relative transfection of the APP
 
Figure 23 (upper panel)
APP C-terminus immunoblot), CTF
(‘CTPs’, bands below 37 KDa, only present in APP
decreased with time of transfection (as do full
bands increased with DAPT incub
In terms of cytoskeleton proteins,
with APP-GFP expression, an effect not mediated by sAPP as actin levels are not altered 
addition, but potentially by AICD, as DAPT incubation partially reverts the decrease. Further, 
tubulin levels were also affected by APP
 
-GFP transfection on actin, KAI
. Data are presented as fold-increases over the values of N1 sample at 
-GFP proteins at 24h.
 shows that upon APP-GFP transfection (bands a and b in the anti
-GFP and AICD-GFP fragments are produced, as expected 
-GFP expressing cells). These fragments 
-length APP-GFP proteins), and while CTF
ation (arrow), AICD-GFP disappeared (arrowhead
 Figure 24-A shows that in general actin levels decrease
-GFP, as Wt APP-GFP expression decreased
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markedly. Of note, protein levels were corrected for the relative initial transfection levels of the 
APP-GFP proteins (24h). 
Concerning the protein expression of potential AICD-target genes, GSK-3β, KAI-1 and 
TAGLN appear to be sensitive to AICD production in SH-SY5Y cells. These proteins exhibited an 
increase in their protein levels in cells producing AICD-GFP (24h, APP-GFP versus N1 expressing 
cells), reached a plateau with time of transfection (48h), and decreased (or even disappeared) 
with DAPT incubation (48h+DAPT). GSK-3β is the most sensitive AICD target gene of the ones 
evaluated, showing higher increases in APP-GFP transfected cells, and TAGLN is the less sensitive 
that showed lower increases over N1. Additionally, KAI 1 and GSK-3β are sensitive to the S655 
phosphorylation state of APP. At 24h the S655A mutant was not able to induce KAI-1, and GSK-3β 
was highly induced by S655E. However, at 48h the levels of these proteins were higher for S655A. 
Very interestingly, most of these potentially AICD-induced genes protein products reached a 
plateau at 48h, while APP-GFP and AICD levels decrease with time. Furthermore, sAPP addition 
did not increase any of these proteins, and even decreased GSK-3β levels at 48h, what will be 
addressed in future experiments.  
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5. Discussion 
 
In the present work we addressed the ability of APP (and its proteolytic fragments sAPP 
and AICD) to mediate neuronal differentiation, namely morphogenic and neuritogenic alterations, 
and the role played by APP phosphorylation at S655 in those processes.  
 
We have first concluded that the Turbofect lipid reagent method is a more suitable 
method for APP cDNAs transfection of SH-SY5Y cells than the Cap-glycerol method. In fact, other 
authors were able to transfect SH-SY5Y cells using the Lipofectamine reagent, a lipid-mediated 
method very similar to Turbofect [119], but more expensive. Nonetheless, Ruiz-León and Pascual 
(2003) efficiently transfected SH-SY5Y using CaP-Glycerol, but used a different transfectant cDNA 
and a more moderate differentiation condition (1 μM RA)[104]. 
Furthermore, we also gather evidence that the percentage of differentiated cells is 
sensitive to the differentiation conditions used and to cell transfection, upon four days of 
differentiation. The mean neurite length was not affected by the differentiation conditions tested, 
what may be due to the early time point of differentiation in cause. Based on the percentage of 
differentiated cells, we established that the best combination of FBS/RA for differentiation of 
both control and transfected SH-SY5Y cells, requires a percentage of 10% FBS, acting as a 
protective agent against the prejudice of the combination of higher RA concentrations and APP 
transfection. As the 10 μM RA/10% FBS combination rendered the most homogeneous results in 
terms of percentages of cell differentiation, it was our elected combination for subsequent assays. 
In fact, several authors report the use of 10 μM RA/10% FBS to accomplish SH-SY5Y neuronal-like 
differentiation [105, 119-121]. 
 
Following, we evaluated the effects of APP overexpression in SH-SY5Y cells differentiation, 
and the role played by APP phosphorylation at S655 in this process. For that, SH-SY5Y cells were 
incubated in 10 μM RA/10% FBS media for fours days, being transfected at the second day of 
differentiation with the vector EGFP-N1 or the Wt, S655A and S655E APP-GFP cDNAs. Table 6 
resumes the APP-GFP-induced alterations that we have observed, relative to control conditions 
(cells transfected with the EGFP-N1 vector). 
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Table 6. Summary of the effects of overexpressing APP with APP-GFP cDNAs, and of mimicking APP phosphorylation 
in an early SH-SY5Y differentiation period (4 days). APP-GFP cDNAs effects were compared to the N1-EGFP ones. 
 
Symbols used: arrows indicate increases or decreases; ≈ indicates maintenance. 
 
 
APP-GFPs transfection significantly increased the levels of full-length APP. However, while 
for the phosphomimicking S655E mutant it resulted in similar sAPP/APP ratios as N1-EGFP 
transfected cells, this was slightly lower for the Wt APP-GFP protein and decreased to half for 
S655A APP-GFP. These suggest that the α-secretase enzyme is not highly activated at this time 
point of differentiation, and when overexpressing its substrate APP this pathway was somehow 
saturated; the fact that S655E seemed a better substrate for this pathway is not surprising, since 
this was already observed to occur in COS-7 cells [89-90]. 
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In addition, APP-GFP overexpression decreased all the microtubule-associated 
differentiation markers analysed (degree of α-tubulin acetylation; levels of the MAP-2 isoforms), 
with S655E mutant presenting the highest decreases in tubulin acetylation and MAP-2a/b levels. 
Interestingly, this is the same mutant that was able to raise the percentage of differentiated cells 
and to markedly increase the neurite length. In contrast, Wt and S655A mainly decreased the 
morphometric parameters. Further, all APP-GFP proteins led to different F-actin rearrangements. 
While Wt and S655A resulted in higher destabilization of the basal F-actin fibres, S655E APP-GFP 
transfected cells decreased less the number of cells with F-actin stress fibers and led to more 
moderated increases in the intermediate and cortical phenotypes.  
In synthesis, Wt APP overexpression resulted in lower degree of cell differentiation, what 
maybe related to its lower sAPP/APP ratio and higher degree of destabilization of the 
microtubules and actin cytoskeletons. Mimicking S655 phosphorylation through the use of the 
S655E mutant lessens this detrimental effect and is even able to surpass it, enhancing the number 
of differentiated cells and neurite length, while the dephosphomimicking S655A mutant did not 
enhance the number of differentiated transfected cells.  
The positive effects of S655E in neurite length are most probably related to its higher 
sAPP/APP ratio, since sAPP is described to be neuritogenic, and S655E transfection was able to 
enhance differentiation in non-transfected neighbour cells. Furthermore, they may also be related 
to its ability to lead to more moderated F-actin fibers destabilization. Apparently, in this initial 
time period of differentiation general microtubule instability and moderated F-actin instability 
direct neurite elongation modulated by APP phosphorylation. However, apparently in 
disagreement with the established models of neurite differentiation describing the requirement 
of microtubule stability and actin instability for neuritogenesis to occur, the present results are 
not totally contradictory to the models of cytoskeleton dynamics in neuronal differentiation. In 
fact, taking a closer look to the results, we can correlate the decreased levels of acetylated tubulin 
to necessary local microtubule instability at neuronal tips in order to enable neurite elongation. 
Furthermore, S655E transfection resulted in similar levels of the low molecular weight MAP-2c/d 
isoforms to N1-EGFP transfected cells, and the MAP-2c isoform was associated to the linkage of 
microtubules with actin cytoskeleton. Regarding F-actin, a certain degree of actin instability is 
necessary for the protruding of processes and for exiting a quiescence state, but our results point 
that a certain degree of stability is necessary during or at the end of neurites elongation.  
By its turn, S655A APP-GFP transfected cells were associated with a statistic significant 
decrease in the sAPP/APP ratio, concordant with the already reported delayed sAPPα secretion 
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[89-90]. The decreased percentage of S655A differentiated cells may be also related to its marked 
increase in a cortical F-actin phenotype, indicative of increased actin fibers disorganization within 
the cell body and clumping of actin fibers at the periphery, as seen by Müller et al (2003), 
following AICD and FE65 cell overexpression [118]. As typical neurites are very dynamic, 
elongating in a saltatory manner, with periods of abrupt advances alternating with periods of 
retraction and pausing[115], the S655A enhanced F-actin instability may alters these balance and 
led to a higher level of retraction and shorter periods of quiescence. Further experiments on the 
mechanisms underlying APP-GFP-induced actin dynamics will be conducted, in order to better 
understand the results. 
The observed inhibitory net effects of Wt APP-GFP in differentiation could be morphogen-
dependent, time-dependent, and AICD-dependent. Indeed, the APP fragment AICD may mediate 
part of the inhibitory effects, since it has been related with actin dynamics and cortical F-actin 
phenotype[118]. Further, in this experiment, APP-GFP transfection was let to occur for 48h, a 
period long enough for AICD-induced gene transactivation to occur and render visible effects, and 
AICD was recently correlated with low degree of PC12 differentiation and stem cells neurogenesis 
[107-108].  
Thus, we have further analyzed in detail which morphologic alterations, related to 
neuronal-like differentiation, could be induced by APP in a time-dependent manner, and the 
influence of APP S655 phosphorylation and AICD generation in these effects. For these, non-
differentiated SH-SY5Y cells were transfected with Wt, S655A, and S655E APP-GFP cDNAs for 24 
and 48h, the later in the presence or not of DAPT, a drug that inhibits CTF cleavage to AICD.  
First, APP-GFP proteins were again observed to decrease cell number, as in the RA-
induced differentiation assays, probably by its observed increase in cell death, and potentially by 
blocking proliferation[122]; we also observed that the AICD appears not to be the main fragment 
involved, contrary to what was reported for RA-induced P19 differentiated cells [123]. 
Nonetheless, APP CTFs may also induce cell death [124], and thus DAPT incubation renders no net 
effect since it inhibits one fragment (AICD) but favors the other (CTF).  
Following, several morphologic alterations and the levels of putative AICD-dependent 
genes were monitored in these conditions, and  
Table 7 summarizes the results obtained. For a easier interpretation, data obtained from 
APP-GFP transfection at 24h was compared to EGFP-N1 data also at 24h; 48h data was compared 
to 24h data (eg increase or not over the same conditions at 24h); 48h + DAPT data was compared 
to 48h data (eg decrease over the same basal DAPT minus conditions at 48h). 
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Table 7. Summary of the S655 phosphorylation-dependent effects of APP and AICD  in cells morphology and in the 
expression of relevant proteins. 
* cells become more elongated, but as these cells are also more plastic, they were scored as ‘plastic’. Symbols used: 
arrows indicate increases or decreases; ≈ indicates maintenance; Ø indicates complete inhibition (absence). 
 
APP-GFP 24h transfection was observed to increase cell elongation and plasticity. Very 
importantly, APP phosphorylation at S655 favours even more elongated morphologies. However, 
48h of APP-GFP transfection led to less elongated morphologies and generally appeared to lead to 
some undifferentiation. This could be reverted by DAPT incubation that was able to further 
increase cell elongation and plasticity in comparison to the 24h time point. Such patterns suggest 
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that AICD inhibits to some extent cell plasticity and elongation, favouring the regular cuboid 
phenotype. 
Moreover, initial APP-GFP transfection was able to positively influence all the 
morphometric parameters, mainly the number of processes per cell, but also the percentage of 
cells with pre-neurites and neurites, pre-neuritic lenght, and the number of pre-neurites and 
neurites per cell. Indeed, at 24h, APP-GFP transfection itself was able to induce differentiation 
(cells with neurites). Very interestingly, 48h of APP-GFP transfection had a negative influence on 
neuritogenesis, leading to a decrease in such parameters (as in the first experiment, with RA 
incubation). Remarkably, if cells were treated with DAPT in the last 24h, this drug was able to 
totally reverse these APP transfection time-dependent decreases, connecting the AICD with APP 
negative modulation of neurite formation, as already suggested by other authors [107-108]. 
Regarding actin dynamics, APP-GFP transfections both resulted in decreased actin levels 
and increased percentages of lamellipodia. So it appears that APP cDNAs transfection is sufficient 
to alter actin dynamics in order to promote lamellipodia advance. Again, it is important to note 
that the S655E rendered higher percentage of cells with lamellipodia, which can be associated 
with its ability to less perturb F-actin stability and potentially to its elongated phenotypes. 
Although AICD is being related with destabilization of actin fibers, this APP-GFP-induced 
lamellipodia effect appears to be AICD-independent (since DAPT did not inhibit this effect). 
In synthesis, APP-GFP overexpression initially induces morphologic alterations leading to 
higher cellular differentiation, but with time of transfection these effects are reverted, cells tend 
to be less differentiated in morphology and neurites tend to retract. This appears to involve AICD-
dependent mechanisms since DAPT incubation partially retained APP-GFP-induced cell body 
elongation, and completely reverted neuritogenesis inhibition. Of note, S655 phosphorylation 
enhances APP-GFP-induced differentiation but was not able to block time-dependent inhibitions.  
Hence, we went on to analyze the levels of putative AICD-dependent protein products, to 
see if any of these proteins profile could correspond to the pattern of alterations monitored. 
When transfecting SH-SY5Y cells with APP-GFP, the levels of AICD increased, and the protein 
expression of the AICD-target genes monitored altered in a fashion consistent with increased 
AICD signaling. In addition, the levels of GSK-3β, TAGLN and KAI-1 further increased upon 48h of 
transfection and decreased after incubation with the γ-secretase inhibitor DAPT, what correlates 
well with the 48h inhibition and with the recovery of the morphometric parameters upon AICD 
inhibition. Moreover, DAPT incubation led to even lower protein levels that the ones presented in 
the 24h condition, what may explain the exacerbated processes outgrowth presented by these 
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cells. Mechanistically, the decrease in GSK-3β is most possible accompanied by a concomitant 
decrease in its activity, which may lead to reduced MAPs phosphorylation, microtubule stability, 
and thus alter neuritic morphology. Transgelin levels were also implicated in the organization of 
actin fibers, and may therefore influence neuritogenesis[118]. In contrast, KAI-1 is a metastasic 
inhibitor, anti-proliferative, and so it should potentially have positive influences in differentiation, 
by inducing a block in proliferation. However, as the γ-secretase has other substrates, further 
studies are required to establish which AICD-induced mechanism(s) and gene target(s) are 
responsible for the neurite outgrowth retraction.  
 
6. Conclusion 
 
The experiments performed in this work indicate that a more sustained (48h) 
overexpression of APP cDNAs can be detrimental to neuronal-like differentiation, inducing an 
overall inhibition of differentiation parameters. We gathered evidence that the APP proteolytic 
fragment AICD may mediate such retraction on SH-SY5Y neuritogenic output. In contrast, more 
immediate (24h) increases in the levels of APP may be beneficial for neurite outgrowth and APP 
alone is, indeed, able to trigger neuronal-like morphological alteration in SH-SY5Y cells. Moreover, 
such positive effects seem to be dependent on S655 APP phosphorylation. In fact the S655E 
mutant was in general able to more markedly induce the differentiation process, most likely due 
to its higher sAPP/APP ratio and less moderate F-actin instability. Further, as 48h of S655E 
expression was able to increase differentiation over N1 control only in RA-differentiated cells, one 
can speculate that RA, a natural morphogen, is able to attenuate in some extent the APP-GFP 
detrimental effects. The nature of the AICD-induced inhibitory signalling mechanisms will be 
evaluated in future experiments. 
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Appendix 
 
Cell Culture Solutions 
 
 PBS (1x) 
 
For a final volume of 500 ml, dissolve one pack of BupH Modified Dulbecco’s Phosphate Buffered 
Saline Pack (Pierce) in deionised H2O. Final composition: 
- 8 mM Sodium Phosphate 
- 2 mM Potassium Phosphate 
- 140 mM Sodium Chloride 
- 10 mM Potassim Chloride 
 
Sterilize by filtering through a 0.2 µm filter and store at 4oC. 
 
 10 mg/ml Poly-D-lysine stock (100x) 
 
To a final volume of 10 ml, dissolve in deionised H2O 100 mg of poly-D-lysine (Sigma-Aldrich). 
 
 Poly-D-lysine solution 
 
To a final volume of 100 ml, dilute 1 ml of the 10 mg/ml poly-D-lysine stock solution in borate 
buffer. 
 
 10% FBS MEM:F12 (1:1) 
- MEM (Gibco, Invitrogen)        4,805 g 
- F12 (Gibco, Invitrogen)        5,315 g 
- NaHCO3 (Sigma)         1,5 g 
- Sodium pyruvate (Sigma)        0,055 g 
- Streptomycin/Penicillin/Amphotericin solution (Gibco, Invitrogen)   10 mL 
- 10% FBS (Gibco, Invitrogen)       100 mL 
- L-glutamine (200 mM stock solution)  2,5 mL 
 
→ Dissolve in distilled (d) H2O; 
→ Adjust the pH to 7.2/ 7.3; 
→ Adjust the volume to 1000 mL with dH2O. 
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 Freezing medium 
 
- Growth medium (MEM:F12)    7 mL 
- FBS (10-20%)      2 mL 
- Glycerol (10-15%) or DMSO (5-20%)   1 mL 
 
 
 
Calcium-phosphate-mediated Transfection Solutions 
 
 2x HEPES-buffered saline (HBS) 100 mL 
- NaCl  280 mM  1,6 g 
- KCl   10 mM   0,074 g 
- Na2HPO4.2H2O 1,5 mM   0,0213 g 
- Dextrose  12 mM   0,2 g   
- HEPES  50 mM   1 g 
 
→ Dissolve in a total volume of  90 mL of distilled (d)H2O; 
→ Adjust the pH to 7.05 (with 0.5N NaHO); 
→ Adjust the volume to 100 mL with dH2O; 
→ Sterilize the solution by passing it through a 0.22-µm filter; 
→ Store the filtrate in 5 mL aliquots at -20ºC. 
 CaCl2 2M solution 
- CaCl2.6H2O  10,8 g  or 
- CaCl2.2H2O  5,88 g 
→ Dissolve in a final volume of 20 mL of dH2O; 
→ Sterilize the solution by passing it through a 0.22-µm filter; 
→ Store in 1 mL aliquots at 4ºC. 
 0,1x TE solution (pH 8.0)   40 mL 
- Tris.Cl solution (pH 8.0)  1 mM  40 µL 
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- EDTA solution (pH 8.0)  0,1 mM  8 µL 
→ Sterilize the solution by passing it through a 0.22-µm filter  
→ Store in aliquots at 4ºC. 
 Glycerol (15% v/v) in 1x HBS 20 mL  
- 10 mL 2x HBS 
- 3 mL glycerol  
- 7 mL dH2O 
→ Add the 15% autoclaved glycerol to filter-sterilized HBS solution just before use. 
 
SDS-PAGE and Immunoblotting Solutions 
 
 LGB (Lower gel buffer) (4x) 
 
To 900 ml of deionised H2O add: 
- Tris  181.65 g 
- SDS  4 g 
 
Mix until the solutes have dissolved. Adjust the pH to 8.9 and adjust the volume to 1L with 
deionised H2O. 
 
 UGB (Upper gel buffer) (5x) 
 
To 900 ml of deionised H2O add: 
- Tris  75.69 g 
 
Mix until the solute has dissolved. Adjust the pH to 6.8 and adjust the volume to 1 L with 
deionised H2O. 
 
 30% Acrylamide/0.8% Bisacrylamide 
 
To 70 ml of deionised H2O add: 
- Acrylamide  29.2 g 
- Bisacrylamide  0.8 g 
 
Mix until the solute has dissolved. Adjust the volume to 100 ml with deionised water. Filter 
through a 0.2 µm filter and store at 4oC. 
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 10% APS (ammonium persulfate) 
 
In 10 ml of deionised H2O dissolve 1 g of APS. Note: prepare fresh before use. 
 
 10% SDS (sodium dodecilsulfate) 
 
In 10 ml of deionised H2O dissolve 1 g of SDS.  
 
 Loading Gel Buffer (4x) 
 
- 1 M Tris solution (pH 6.8)  2.5 mL (250 mM) 
- SDS    0.8 g (8%) 
- Glicerol    4 ml (40%) 
- β-Mercaptoetanol  2 ml (2%) 
- Bromofenol blue   1 mg (0.01%) 
 
Adjust the volume to 10 ml with deionised H2O. Store in darkness at room temperature. 
 
 
 1 M Tris (pH 6.8) solution 
 
To 150 ml of deionised H2O add: 
- Tris base  30.3 g 
 
Adjust the pH to 6.8 and adjust the final volume to 250 ml. 
 
 10x Running Buffer 
 
- Tris  30.3 g (250 mM) 
- Glycine  144.2 g (2.5 M) 
- SDS  10 g (1%) 
 
Dissolve in deionised H2O, adjust the pH to 8.3 and adjust the volume to 1 L. 
 
 Resolving (lower) gel solution (60 ml) 
 
 7.5%                or 10%  
- H2O 29,25 ml  25,2 ml 
- 30% Acryl/0.8% Bisacryl solution 15 ml  19,8 ml 
- LGB (4x) 15 ml  15 ml 
- 10% APS 300 µL  300 µL 
- TEMED 30 µL  30 µL 
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 Resolving (lower) gel solution for gradient gels (60 ml) 
 
 5%                and 20%      
- H2O 17.4 ml  2.2 ml 
- 30% Acryl/0.8% Bisacryl solution 5 ml  20 ml 
- LGB (4x) 7.5 ml  7.5 ml 
- 10% APS 150 µL  150 µL 
- TEMED 15 µL  15 µL 
 
 
 Stacking (upper) gel solution (20 ml) 
 
 3.5%                
- H2O 13.2 ml 
- 30% Acryl/0.8% Bisacryl solution 2.4 ml 
- UGB (5x) 4.0 ml 
- 10% APS 200 µL 
- 10% SDS 200 µL 
- TEMED 20 µL 
 
 
 1x Transfer Buffer 
 
- Tris  3.03 g (25 mM) 
- Glycine  14.41 g (192 mM) 
 
Mix until solutes dissolution. Adjust the pH to 8.3 with HCl and adjust the volume to 800 ml with 
deionised H2O. Just prior to use add 200 ml of methanol (20%). 
 
 
 10x TBS (Tris buffered saline) 
 
- Tris  12.11 g (10 mM) 
- NaCl  87.66 g (150 mM) 
 
Adjust the pH to 8.0 with HCl and adjust the volume to 1L with deionised H2O. 
 
 10x TBST (TBS+Tween) 
 
- Tris  12.11 g (10 mM) 
- NaCl  87.66 g (150 mM) 
- Tween 20  5 ml (0.05%) 
 
Adjust the pH to 8.0 with HCl and adjust the volume to 1L with deionised H2O. 
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 Membranes Stripping Solution (500 ml) 
 
- Tris-HCl (pH 6.7)   3.76 g (62.5 mM) 
- SDS    10 g (2%) 
- β-mercaptoetanol  3.5 ml (100 mM) 
 
Dissolve Tris and SDS in deionised H2O and adjust with HCl to pH 6.7. Add the mercaptoethanol 
and adjust volume to 500 ml. 
 
 
 
 
 
 
 
